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Abstract 
Using data for 939 publicly listed firms from 17 European countries over the period from 2004 to 2013, we 
investigate the effect of used credit lines on R&D investments, controlling for other determinants of R&D 
investments, i.e., cash flows, cash holdings, sales growth, equity financing, and Tobin’s Q. Our estimation 
results, based on the system-GMM method, show that used credit lines have a positive and significant 
impact on R&D investments. In addition, we find that this impact is more pronounced for small and young 
firms than for large and mature firms. These results show that firms use credit lines as part of their liquidity 
management tools for supporting their R&D investments. Finally, we provide evidence that European firms 
in bank-based countries increased their use of credit lines for financing their R&D investments during the 
financial crisis of 2007-2009, while the link between R&D investments and used credit lines became 
weaker during the European sovereign debt crisis of 2010-2013.  
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1. Introduction 
It has long been viewed that research and development (R&D) investments are the ‘engine 
of economic growth’ determining the long-run economic growth rate (e.g., Romer, 1990; Akcigit 
and Kerr, 2015). Recently, one of the major objectives of the European Commission has been to 
increase R&D investments as an important stimulus for fostering Europe’s competitiveness 
(Bilbao-Osorio, 2014).1 In this paper, we aim to improve our understanding of financing R&D 
investments by examining how the components of bank debt could influence firms’ R&D 
investment decisions. In particular, we focus on the role of credit lines (i.e., revolving credit 
facilities) in determining the level of R&D investments for a sample of European firms. In the 
extant literature, credit lines have been viewed as a component of bank debt, which can help firms 
with their liquidity management, mitigating financial market frictions (e.g., Lins et al., 2010; Sufi, 
2009).  
Firms can use three main sources of financing for their R&D investments: internally 
generated cash as an internal source, and net stock issues and/or debt as external sources (e.g., 
Ozkan, 2002; Brown et al., 2009; Hall and Lerner, 2010). There have been mixed findings on the 
impact of these sources of financing on R&D investments. Prior studies have mainly treated debt 
as a uniform variable and do not consider the role of different debt components, i.e., bank debt, 
including used credit lines and term loans, in determining the level of R&D investments. Bank 
debt, which is a common source of financing for European firms (Demirguc-Kunt and Levine, 
                                                     
1 European countries constitute a considerable portion (around a quarter) of global R&D spending. The Lisbon 
strategy set for the European Union an objective of devoting 3 % of its GDP to R&D investments by 2010. However, 
the target was not reached, and subsequently, the European Commission decided to maintain the 3 % target.  
Currently 2 % of the GDP in Europe is devoted to R&D investments, lagging behind Japan (3.4 %) and the US (2.8 
%). See the article, ‘EU must spend more on research and development’, Financial Times, May 19, 2014, and ‘Europe 
continues to fall behind in race to innovate’, Financial Times, December 16, 2014. 
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2001), could be important for financing R&D investments. A recent survey by Campello et al. 
(2012) also highlights the role of bank financing for European firms. They argue that the use of 
credit lines can be important in understanding how firms manage their liquidity, particularly 
during financial crises. Differently from prior studies, our paper investigates the impact of used 
credit lines, which is a component of bank debt, on R&D investments. Further, we explore 
whether our sample of European firms relied on credit lines for financing their R&D investments 
during the recent financial crisis and the Euro area sovereign debt crisis.  
Our approach is motivated by Chava et al. (2013) and Amore et al. (2013), who emphasize 
the role of bank lending in determining corporate innovation outcomes, i.e., the number and 
quality of patents.2 Amore et al. (2013) document that interstate bank deregulation had a positive 
effect on the innovation of public firms, while Chava et al. (2013) report that interstate bank 
deregulation fostered the innovation of young and private firms. However, these studies do not 
establish whether the increase in innovation stems directly from bank financing for firms’ R&D 
investment. Given their empirical evidence of a significant relationship between bank lending and 
innovation, one can argue that R&D investments, which have been viewed as one of the inputs for 
innovation, can be associated with firms’ access to bank debt.3 In fact, anecdotal evidence from 
Europe shows that some firms rely on bank financing to fund their R&D investments. For 
instance, recently, Konecranes, a Finnish firm, signed a €50 million loan for R&D purposes with 
Nordic Investment Bank. This loan will be used for funding R&D activities in the fields of 
machine artificial intelligence and new mid-market equipment until 2017. Further, this loan 
                                                     
2 More recently, Atanassov (2016) investigates the impact of various forms of financing sources on innovation for a 
sample of US firms, including bank debt, equity financing and public debt.   
3 See Knott (2008) about inputs of innovation. 
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agreement follows the borrower's €100m five-year credit line facility refinancing, signed in 
February 2014.4 
The extant literature provides ambiguous predictions about the relationship between bank 
financing and R&D investments. On the one hand, the nature of debt contracts, particularly bank 
financing, may not be well suited for R&D investments for various reasons (e.g., Carpenter and 
Petersen, 2002). For instance, lenders do not share gains from R&D projects, while they are 
subject to losses from a potential downside.5 Thus, banks could be reluctant to lend to firms 
involved in R&D activities. On the other hand, bank debt can have considerable advantages over 
public debt for firms involved in R&D activities. Prior studies have highlighted banks’ role of 
effective monitoring, as they have access to private information about the firms with whom they 
have lending relationships (e.g., Bolton et al., 2016). Therefore, they could reduce potential moral 
hazard problems and provide firms with strong incentives to make appropriate corporate 
decisions. Specifically, for R&D investments, which involve a high degree of information 
asymmetry between insiders and outside investors, bank debt could be considerably helpful in 
reducing potential information asymmetries.6 
Furthermore, credit lines, which are a component of bank debt, can provide liquidity 
insurance for firms, i.e., firms can draw on their credit lines when accessing external capital 
markets becomes more restricted (e.g., Almeida et al., 2014). Hence, firms involved in R&D 
activities may use credit lines to smooth their R&D investments, which could involve a 
considerably high level of adjustment costs (Bernstein and Nadiri, 1989). In particular, credit lines 
                                                     
4 Commerzbank, Danske Bank, Nordea, Pohjola Bank and SEB were mandated lead arrangers and book-runners on 
the credit lines. Danske Bank was the facility agent. See Global Capital (2014) magazine. 
5 Moreover, firms with R&D projects may not offer good collateral value and may suffer from credit rationing arising 
from the adverse selection problem (Stiglitz and Weiss, 1981; Hall, 2002).   
6 Chava et al. (2015) provide empirical evidence that bank financing can be an important source of financing for 
innovative firms, and banks price their loans to innovative firms considering these firms’ intellectual property, i.e., 
patent stock. However, they do not explore whether bank financing influences R&D investments. 
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can play an important role in firms’ financing of their R&D investments during a period of 
exogenous shock, e.g., a financial crisis. We can view credit lines as a put option, since firms can 
use them at  pre-arranged low rates if the spot-market interest rates are high (e.g., Berg et al., 
2016). 
For our empirical analysis, we use a sample of 939 European firms for the period 2004 to 
2013. To estimate the impact of bank debt components on R&D investments, we employ the 
system-GMM estimation method developed for dynamic panel models, which provides a joint 
estimation of a regression model in differences and levels (e.g., Flannery and Hankins, 2013).7 
The system-GMM method addresses the potential endogeneity problems in our regression model, 
where R&D investments, bank debt components and other financial variables could be 
simultaneously determined (e.g., Brown et al., 2012; Brown and Petersen, 2011). Alternatively, 
the relation between R&D investments and bank debt components can suffer from reverse 
causality. Further, we use a difference-in-differences approach to examine the impact of the 2007-
2009 financial crisis and the Euro area sovereign debt crisis on firms’ financing of R&D 
investments.  
Our results support the view that banks can play an important role in determining the level 
of R&D investments in European firms. We find that used credit lines have a positive and 
significant impact on R&D investments, while the coefficient estimate for term loans is not 
statistically significant. This result is consistent with the view that credit lines are more flexible 
than term loans and provide financing for smoothing R&D investments. Further tests show that 
our sample of European firms draw funds from their credit lines to finance their R&D investments 
when they are faced with a cash shortage, or their access to equity financing is more limited.  Our 
                                                     
7 That is, lagged levels are used as instruments for the equations in differences, while lagged differences are used as 
instruments for the equations in levels.   
5 
 
finding for used credit lines is also economically significant: a one-standard deviation increase in 
the used credit lines-to-total assets ratio is associated with a 65.64 basis point increase in the 
R&D-to-total assets ratio. These results provide support for the survey findings from Lins et al. 
(2010), showing that firms with growth opportunities, i.e., R&D activities, rely on credit lines as 
part of their liquidity management tools. Similar to the results from Brown and Petersen (2011), 
we also find that our sample of European firms relies on their cash holdings in financing their 
R&D investments. Notably, our results show that firms most likely to be financially constrained, 
i.e., small and young firms, rely relatively more on credit lines as a source of financing for their 
R&D investments than mature and large firms. Further, we observe that the link between R&D 
investment and used credit lines stays positive and significant during the 2007-2009 financial 
crisis and the European sovereign debt crisis. This finding is consistent with the view that the 
European banking system is mainly a relationship-based banking system, which can help firms 
weather crisis times better, given that they can continue to borrow from their banks (e.g., Ongena 
and Smith, 2000; Bolton et al., 2016). Thus, credit lines help firms protect their R&D investments 
during a period when access to alternative sources of financing becomes more limited.  
We conduct further tests by incorporating country-level financial structure characteristics, 
i.e., the ratio of credit market development to stock market development, into our analysis. 
Following Demirguc-Kunt and Levine (2001) and Didier et al. (2014), we split our sample of 
European countries into bank-based and market-based countries, considering their ratio of credit 
market development to stock market development. Firms in market-based countries with relatively 
easy access to equity markets would not be expected to rely as much on credit lines as a source of 
financing for their R&D investments as firms in bank-based countries would. Our results provide 
evidence consistent with this prediction. We find that the link between R&D investments and used 
credit lines is stronger in bank-based countries than market-based countries.  
6 
 
Additionally, our results show that firms in bank-based countries increased their use of 
credit lines during the 2007-2009 crisis. This finding suggests that relationship banking, which is 
more likely to be prevalent in bank-based countries, can help firms weather crises more smoothly. 
However, these firms in bank-based countries reduced their reliance on credit lines as a source of 
financing for their R&D investments during the Euro area sovereign debt crisis. This finding is 
consistent with prior studies reporting that banks in Europe reduced their lending considerably 
more during the sovereign debt crisis than the 2007-2009 financial crisis (e.g., Becker and 
Ivashina, 2016). 
Our paper makes a number of contributions to the literature. First, while Chava et al. 
(2013), Amore et al. (2013) and Atanassov (2016) document that bank lending can influence 
innovation, we are the first (to our knowledge) to investigate the relation between bank debt, i.e., 
used credit lines and term loans, and a firm’s R&D investment decisions. Second, we extend the 
literature on the real effects of financial crises by providing evidence that European firms in bank-
based countries increased their use of credit lines as a source of financing for their R&D during 
the financial crisis of 2007-2009, while they reduced their reliance on credit lines for financing 
their R&D investments during the Euro area sovereign debt crisis of 2010-2013. To our best 
knowledge, this is the first study investigating the effect of the recent financial crises on the 
financing of R&D investment for European firms. Our findings complement the results from prior 
surveys that reported an increased use of credit lines during the recent financial crisis (e.g., 
Campello et al., 2012; Campello et al., 2010).  
The rest of the paper proceeds as follows. The next section provides the literature review 
and hypotheses development. Section 3 discusses our regression model and estimation method. 
Section 4 reports the data characteristics. Section 5 discusses our findings, and Section 6 
concludes.   
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2. Literature review and hypotheses development 
R&D investments have some specific characteristics, which may have direct implications 
about how they are financed. Notably, R&D activities involve a great degree of uncertainty, 
intangible capital and information asymmetry between insiders and outside investors about their 
potential output and financial return (see e.g., Aboody and Lev, 2000; Knott, 2008). Given these 
characteristics of R&D investments, firms are less likely to rely on debt as a source of financing 
for their R&D activities (e.g., Hall and Lerner, 2010).  For instance, Brown et al. (2012) and Hall 
(1992) provide empirical evidence that European and US firms do not rely on debt financing for 
funding their R&D investments.     
Previous studies have mainly highlighted the role of internal financing, i.e., cash flows and 
cash holdings, and equity issuance in financing R&D investments.  Equity financing has several 
advantages as a source of financing for R&D investments (e.g., Carpenter and Petersen, 2002).  It 
does not require collateral, and upside returns for investors are not bounded.  Further, it does not 
lead to an increase in the likelihood of financial distress. For a sample of 16 major European 
countries over the period 1995-2007, Brown et al. (2012) find that equity financing could be an 
important source of financing for R&D investments.  Carpenter and Petersen (2002) also 
investigate the importance of equity financing for US high-tech companies over the period 1981-
1998. They find that equity finance plays a crucial role for firms.  In addition, Brown et al. (2012) 
show that cash flows have a positive and significant effect on R&D investment for European 
firms. Brown and Petersen (2015) also find a positive relation between cash flows and R&D 
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investments for US firms. Further, Brown and Petersen (2011) show that cash holdings can be 
used as a buffer for smoothing R&D investments, which involve relatively high adjustment costs.8  
 Prior studies have mainly provided evidence about the role of cash flows, cash holdings, 
equity issuance and debt in determining R&D investments.  However, there has been no study, to 
our knowledge, which examines whether bank debt and its components can play a role in 
financing R&D investments. In the next subsection, we discuss whether bank debt, especially 
credit lines, can provide a source of financing for R&D investments. 
 
2.1. Bank debt, credit lines and R&D investment 
 Recently researchers have documented that there is a significant relationship between bank 
deregulation and innovation, suggesting that bank financing can play an important role in 
determining corporate innovation activity.9 Further, Atanassov (2016) reports that credit lines 
have a positive impact on the novelty of US firms’ innovations.  In this paper, we aim to extend 
this literature by investigating whether R&D investment, as an input of innovation, can be 
influenced by bank financing.   
The extant literature does not offer a distinct explanation about whether bank financing can 
be a possible source of funding for R&D investments.  On the one hand, banks are unlikely to 
extend financing to firms with R&D investments, as these investments have a high degree of 
uncertainty, information asymmetry and risk.  On the other hand, banks can alleviate information 
asymmetry problems through their monitoring and screening technologies, and can therefore 
reduce the costs of moral hazard and adverse selection (e.g., Diamond, 1991). Further, firms can 
                                                     
8 Researchers previously reported that the salaries of scientists and engineers constituted a major part of R&D 
investments (Hall, 2002; Brown and Petersen, 2011). Therefore, R&D investments can have major adjustment costs 
(e.g., Bernstein and Nadiri, 1989). Firms spend resources investing in the knowledge capital of their R&D employees, 
i.e., scientists. Hence, they would be reluctant to fire them unless there is considerable pressure to do so. 
 
9 See Chava et al. (2013), and Amore et al. (2013).  
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renegotiate and re-contract with their banks when they are in financial distress. In particular, bank 
loans can be part of a long-term relation between banks and firms (e.g., Petersen and Rajan, 1994; 
Hadlock and James, 2002). Thus, firms may be willing to use bank debt for their R&D activities, 
since banks as relational lenders facilitate the continuity of R&D investments when firms are 
financially distressed (Hoshi et al., 1990). 
Moreover, credit lines, which are a component of bank debt and are more flexible than 
terms loans, can help firms smooth their R&D investments.  Given the relatively high adjustment 
costs involved in R&D investments, firms are likely to rely on both their cash holdings and credit 
lines when access to external capital markets becomes limited.  Credit lines allow firms to have 
access to pre-committed financing at a pre-set interest rate.  For this access right, these firms pay 
an additional commitment fee for the unused part of the loan in exchange. Berg et al. (2016) argue 
that credit lines and term loans are different, considering the options embedded in each one and 
their pricing structure. For instance, they identify five different types of fees for credit lines, while 
they find only two fee types for term loan contracts.  Further, Sufi (2009) and Atanassov (2016) 
argue that credit lines are more flexible than term loans. 
Credit lines, hence, can be viewed as a liquidity insurance for firms, as long as banks can 
provide the credit (e.g., Campello et al., 2011).  Prior research on the theory of credit lines has 
considered credit line commitments as insurance against the decline in a firm’s creditworthiness, 
since these commitments offer borrowing firms the option to use credit lines in the case of 
economic deterioration. A borrowing firm will draw down a line of credit, i.e., exercise the option, 
if it is more expensive to borrow in the spot market (e.g., Thakor et al., 1981; Thakor, 1982). 
Theoretically, firms hold liquid reserves (cash holdings) and/or credit lines to protect 
themselves against liquidity shocks (Holmstrom and Tirole, 1998).  Thus, cash holdings and credit 
lines could help firms hedge against liquidity shocks, which could otherwise potentially force 
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them to give up projects with positive net present value. Bolton et al. (2011)’s theoretical model 
shows that there is a pecking order of financing, in the order of internal funds, credit lines, and 
external equity financing.  In their model, credit lines help firms mitigate their underinvestment 
problem when they run out of cash.  Sufi (2009) analyzes a sample of 300 US public firms over 
1996-2003 and shows bank lines of credit are an important financial source, but firms with low 
cash flows are less likely to obtain such lines of credit. The reason is that these firms cannot 
satisfy the loan covenants.  Further, Lins et al. (2010) use survey data from 29 countries and report 
that managers use cash holdings as a way to hedge against negative shocks, while credit lines are 
used to improve firms’ ability to take up future growth opportunities. 
Overall, the current literature highlights two important distinctive characteristics of credit 
lines that separate them from term loans:  flexibility and the liquidity insurance role of credit lines. 
We therefore predict that as a form of bank financing, credit lines rather than term loans play an 
important role in determining R&D investments.  Firms can rely on drawn (used) credit lines, as 
well as other external and internal sources of financing to fund their R&D investments.  The 
relationship between R&D investments and used credit lines could be even stronger for financially 
constrained firms, since these firms are more likely to face liquidity shortages, and therefore need 
more liquidity insurance.   
In this context, we have the following main hypotheses about how credit lines, as part of 
bank financing, can influence R&D investments:  
 
H1.  Credit lines, which are more flexible than term loans, can provide liquidity to smooth firms’ 
R&D investments.  Thus, used credit lines have a positive impact on R&D investments. 
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H2.  The positive impact of used credit lines on R&D investments is more pronounced for 
financially constrained firms, as their access to alternative sources of financing is more limited 
than that for financially unconstrained firms. 
 
2.2. Credit lines and R&D investment during crises 
 Recently, Campello et al. (2012) used survey data from CFOs in European firms to 
investigate credit line withdrawals over the period 2008-2009. They find that firms that cannot 
access credit, i.e., firms that are unprofitable, small, private, and non-investment grade, used more 
credit lines than their counterparts, i.e., firms that are large, public, profitable, and investment-
grade, during the recent financial crises. Their results suggest that firms drew credit lines for their 
liquidity needs to invest during the crises. They also show that large, public, profitable and 
investment-grade European firms used 30%-44% of their available credit lines during the 2008-
2009 crisis period. The use of credit lines was relatively higher among small and less profitable 
firms. On average, they withdrew between 48% and 68% of their available credit during the same 
period.  These findings show that firms can use credit lines during a time of crisis, as long as 
banks can honor these credit line drawdowns.10 Berg et al. (2017) provide further evidence that 
firms are more likely to use credit lines as their economic situation worsens, i.e., their equity 
returns decline.  Jiménez et al. (2009) show that various factors, including firm-specific and 
lender-specific characteristics, and the macroeconomic situation can influence corporate credit 
line usage for their sample of Spanish firms. 
  Moreover, Ivashina and Scharfstein (2010) report that there was a significant increase in 
credit line drawdowns by US firms following the collapse of Lehman Brothers in 2008. In 
                                                     
10 As Almeida et al. (2014) argue, firms’ access to existing credit lines depends on banks’ health. Banks, which are 
exposed to liquidity shocks, can restrict access to existing credit lines.   
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particular, firms with low credit quality increased their drawdowns substantially. Our summary 
statistics in Table 1a also show that from 2006 to 2008, on average, there is around a 35% increase 
in the ratio of used credit lines-to-total assets, which is consistent with Campello et al. (2012)’s 
findings for European firms.11 Prior studies have also used credit register data from various 
European countries to investigate how bank lending changed during the recent financial crises.  
They document that banks continued to extend credit to their long-term clients after the collapse 
of Lehman Brothers (e.g., Beck et al., 2017; Bolton et al., 2016).  This finding suggests that 
relationship lending, which is relatively more common in Europe than in the US, may have 
relaxed the financial constraints faced by European firms during the recent financial crises.  
Further, Berger and Udell (1995) argue that credit lines can be an important part of relationship 
lending, since they represent a forward commitment to provide financing under some pre-
specified terms. 
 We would therefore expect our sample of European firms to continue relying on used 
credit lines to manage their liquidity and fund their R&D investments when there is an exogenous 
shock, e.g., the 2007-2009 financial crisis and Euro area sovereign debt crisis, which makes access 
to alternative financing more difficult.  However, firms’ access to their existing credit lines can be 
limited if banks do not fulfill their commitment to provide these funds (e.g., Jiménez et al., 2009).   
Thus, we posit the following hypothesis: 
 
H3.  As long as banks fulfill their commitments for credit line agreements, firms (particularly 
financially constrained firms) can continue to rely on credit lines as a source of financing for R&D 
investments during a time of exogenous shock, when access to alternative sources of financing is 
limited.   
                                                     
11 We also observe a similar pattern in the ratio of used credit lines to total debt in Table A3 of the Appendix.  
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3. Estimation Method 
 
To test the impact of bank debt on R&D investment, we use a dynamic model derived 
from an Euler equation.  Bond and Meghir (1994) developed this model to study fixed investment 
under the assumption of quadratic adjustment costs. Further, this model incorporates expectations 
that are formed in line with a dynamic optimization approach. Following Brown and Petersen 
(2015), we augment the baseline Euler specification and add Tobin’s Q and Sales growth to 
control for investment demand.12 We also include Cash flow, Stock issues, ∆Cash, and Debt type, 
which represent either Leverage or Bank debt, i.e., Used credit lines and/or Term loans, to account 
for different sources of financing.13 Our specification of the dynamic panel model is as follows: 
𝑅&𝐷𝑖,𝑡 = 𝑏1𝑅&𝐷𝑖,𝑡−1 + 𝑏2𝑅&𝐷𝑖,𝑡−1
2 + 𝑏3𝑄𝑖,𝑡 + 𝑏4𝑄𝑖,𝑡−1 + 𝑏5𝑆𝑎𝑙𝑒𝑠 𝑔𝑟𝑜𝑤𝑡ℎ𝑖,𝑡  
  + 𝑏6𝑆𝑎𝑙𝑒𝑠 𝑔𝑟𝑜𝑤𝑡ℎ𝑖,𝑡−1 + 𝑏7𝐶𝑎𝑠ℎ 𝑓𝑙𝑜𝑤𝑖,𝑡 + 𝑏8𝐶𝑎𝑠ℎ 𝑓𝑙𝑜𝑤𝑖,𝑡−1 +  𝑏9𝑆𝑡𝑜𝑐𝑘 𝑖𝑠𝑠𝑢𝑒𝑠𝑖,𝑡 
+𝑏10𝑆𝑡𝑜𝑐𝑘 𝑖𝑠𝑠𝑢𝑒𝑠𝑖,𝑡−1 + 𝑏11∆𝐶𝑎𝑠ℎ𝑖,𝑡 + 𝑏12∆𝐶𝑎𝑠ℎ𝑖,𝑡−1 +  𝑏13𝐷𝑒𝑏𝑡 𝑡𝑦𝑝𝑒𝑖,𝑡 +
𝑏14𝐷𝑒𝑏𝑡 𝑡𝑦𝑝𝑒𝑖,𝑡−1 + 𝑓𝑖 + 𝑑𝑡 + 𝑒𝑖,𝑡                                                                                (1) 
    
                                              
 
                                      
     
      
                  
where 𝑅&𝐷𝑖,𝑡 is the ratio of research and development investment to lagged total assets for firm i 
in year t. Table A1 in the Appendix provides a definition for each variable used in our empirical 
analysis. 
In our model, we also control for year fixed effects (dt) and firm-specific fixed effects (fi), 
and ei,t represents the error term. All variables, including 𝑅&𝐷𝑖,𝑡, are scaled by firms’ beginning-
of-period total assets to maintain a common scale factor. There are several econometric problems 
                                                     
12 By following the literature, we control for both lagged and contemporaneous values of the explanatory variables 
(Bond et al., 2003; Brown and Petersen, 2015), but our results remain the same if we control for only the 
contemporaneous values of the explanatory variables in our dynamic regressions, including lagged and quadratic 
R&D variables. 
13 In this model, we alternatively consider the flow form of debt type, i.e., net debt issuance, change in bank debt, 
change in used credit lines, and change in term loans. Our results do not change if we use these variables.   
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in the dynamic panel model above. First, in the presence of unobserved firm-specific fixed effects, 
the OLS estimation method will produce biased estimates due to the correlation between the 
lagged dependent variable and unobserved firm-specific fixed effects. Taking the first-differences 
will remove firm-specific fixed effects. However, OLS estimation still will not yield consistent 
estimates, since the first-difference transformation will produce a correlation between ∆R&Di,t-1 
and ∆ei,t through the terms R&Di,t-1 and ei,t-1. Instead of the first-differencing transformation, we 
can use within transformation, but this will then introduce a correlation between the lagged 
dependent variable and time-averaged idiosyncratic error term, which would yield biased 
coefficient estimates. This bias falls with the number of years, T, but this is not the case in our 
empirical analysis, since T in our sample is relatively small.14 
Second, some of our explanatory variables, e.g., Cash flow and Cash, are not strictly 
exogenous. That is, shocks affecting R&D investment decisions of the firms are also likely to 
affect such regressors. Additionally, it is likely that there will be a correlation between some of the 
regressors and the idiosyncratic component of the disturbances’ past and current values.  
To address these econometric problems, we employ the system-GMM dynamic panel data 
estimator (Arellano and Bover, 1995; Blundell and Bond, 1998). One advantage of the system-
GMM estimation is that all variables, including lagged and differenced variables, are potentially 
valid instruments as long as they are not correlated with the error term. The system-GMM 
estimator tackles the potential endogeneity of all variables by jointly estimating the equations in 
differences (i.e., first-difference transformation) and in levels. It also addresses dynamic panel bias 
due to the correlation between the lagged dependent variable and firm-specific fixed effects (e.g., 
Bond et al., 2003; Flannery and Hankins, 2013; Brown and Petersen, 2015).  
                                                     
14 See, for instance, Judson and Owen (1999). 
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The system-GMM method uses lagged levels as instruments for the equation in differences 
and lagged differences as instruments for the equation in levels. In section 5, we report the one-
step system-GMM estimation results employing lagged levels dated t-3 and t-4 as instruments for 
the equation in differences, and lagged differences dated t-2 as instruments for the equation in 
levels.15, 16 In order to ensure the reliability of our econometric methodology, we should have an 
appropriate selection of instruments and no second-order serial correlation.  Thus, we implement 
Hansen’s J-test, the difference-in-Hansen test, and the m2 test to confirm the validity of our 
instruments. In a dynamic panel data regression, we expect to have a first-order serial correlation 
(i.e., m1), but there should be no second-order serial correlation. In Hansen’s J-test of over-
identifying restrictions, the null hypothesis is that the instruments are orthogonal to the error 
process. Therefore, a rejection of the null hypothesis would confirm that the estimates are not 
consistent.  The difference-in-Hansen test assesses the validity of additional instruments for the 
levels equation. We report Hansen’s J-test, the difference-in-Hansen test, and the m2 test statistics 
for diagnostic checks.     
 
4. Data and descriptive statistics 
4.1. Data 
We obtain our firm-level data from Worldscope and Capital IQ databases over the period 
2004 to 2013. Our sample covers 939 firms from 17 major European countries. We remove firms 
with missing SIC codes (N/As), and firms from utilities (SIC codes 4900-4949) and financials 
(SIC codes 6000-6999). We combine our list of firms from Worldscope with those from the 
                                                     
15 We also used alternative instrument sets, such as lagged levels dated t-2 and t-4 and lagged differences dated t-1; 
and lagged levels t-3 and t-5 and lagged differences dated t-2. The results from these alternative instrument sets 
suggest that our findings are consistent.  
16 Since the standard errors from the two-step GMM are downward biased for small samples (Arellano and Bond, 
1991), we use the one-step GMM, as in Brown et al. (2009) and Brown and Petersen (2015). We also tried the two-
step GMM with Windmeijer (2005) corrected standard errors, and the results were still consistent with the one-step 
GMM estimation results. For brevity, we do not tabulate these results. 
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Capital IQ database, which provides bank debt, credit lines and term loan data.17 We keep only 
those firms with positive R&D spending and at least three consecutive observations in all of the 
variables (firms with fewer than three consecutive variable observations do not contribute 
observations to our regressions) in our sample period. Then, we trim our sample at the 1% level 
and end up with 4,246 firm-year observations involving 939 unique firms. Table A2 in the 
Appendix reports the list of the countries and the number of firms from each country, while Table 
A1 presents the list of the variable definitions and their corresponding Worldscope codes. 
 
4.2. Descriptive statistics  
Table 1a reports the summary statistics for the Leverage, Bank debt, Used and Unused 
credit lines, and Term loans for our sample period. All variables are scaled by total assets. In 
Panel A, we observe that, on average, Term loans (11.7%) is larger than Used credit lines (3.6%) 
for the whole period, considering all firms. Our sample size for unused credit lines is 477, which is 
considerably smaller than our full sample size. Thus, we do not include the unused credit line 
variable in our regression analysis, but still report the descriptive statistics for comparison 
purposes. 
Panel B of Table 1a shows that Bank debt and Used credit lines obtain their highest mean 
values in 2008, suggesting that firms used term loans and credit lines when the financial crisis 
started, and their access to external capital markets became relatively more limited. Also, average 
bank debt increases by 17.5% from 2006 to 2008. Further, on average, there is a 35% (13%) 
increase in Used credit lines (Term loan) between 2006 and 2008. We also observe that for most 
                                                     
17 Lin et al. (2013) also extract bank debt, term loan, and credit line data for European countries from the Capital IQ 
database, while Colla et al. (2013) use Capital IQ to obtain debt structure variables for US firms. In our empirical 
analysis, we also test the impact of public debt and its components on R&D investments. However, the sample size is 
reduced by half for the public debt components; in untabulated tests, we find that the coefficient estimates for the 
public debt components are statistically insignificant.  
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of the years, the average Unused credit lines is greater than the average Term loans with respect to 
their mean values. 
[Insert Table 1a here] 
Table 1b presents the summary statistics for R&D, Cash flow, Stock issues, Tobin’s Q, 
Sales growth, Cash, ∆Cash and Employee (number of employees as a firm size proxy), for our 
sample of European firms over the period 2004-2013. In Panel A, we observe that the mean 
(median) R&D is 4% (2.1%); the mean (median) Cash is 12.6% (9.1%); and the median value for 
Employee is 2,841, while its average is 15,860.   
Panel B of Table 1b reports the average value of firm-specific variables from 2004 to 
2013. Notably, the average R&D does not change considerably during our sample period, which is 
consistent with Brown and Petersen (2015), who show that US firms try to protect their R&D 
investments during the financial crisis.18 Further, we can observe that there is a decline in the 
mean Cash flow and Stock issues from 2006 to 2013. When we consider Table 1a and Table 1b 
together, we can say that our sample firms may be substituting credit lines for cash flow and stock 
issuance, as alternative ways of financing R&D investments. Further, mean cash holdings (Cash) 
decline from 2007 to 2008, which could be viewed as the initial years of the financial crisis, but 
firms seem to build up their cash holdings from 2009 to 2013, with an increase of 6.7%.  
[Insert Table 1b here] 
In Table 1c, we split firms into young (small) and mature (large) categories and test 
whether there are significant differences in the mean and median of our firm-specific 
characteristics between those subsamples, which could be classified as financially constrained or 
financially unconstrained, respectively. Consistent with previous studies, we use firm age and firm 
                                                     
18 Survey results by McKinsey show that European firms were able to maintain their R&D activities during the recent 
financial crisis years.  See “R&D in the downturn: McKinsey Global Survey Results”, April, 2009. 
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size for proxies to classify firms as being financially constrained or unconstrained. Following 
Brown et al. (2009) and Brown and Petersen (2015), we compute firms’ age as the number of 
years since their IPO years and classify them as “young” if their age is 15 or less over the period 
2004-2006, and “mature” otherwise. Firm size is another commonly used proxy for being 
financially constrained or financially unconstrained (Farre-Mensa and Ljungqvist, 2016). We 
classify our sample firms as “small” if their average number of employees over the sample period 
is less than the 70th percentile, and “large” otherwise.19  
We observe that, on average, R&D investment ratios for young and small firms are much 
higher than mature and large firms’ corresponding ratios. We also test whether these means 
(medians) are statistically different: the t-test (Wilcoxon) results in columns (4) and (7) strongly 
reject the null hypothesis at the 1% level that the differences between the mean (median) R&D 
ratios are zero. The difference between the mean used credit line ratios for young and mature 
firms are not significant, but the t-test in column (7) for the difference between the mean used 
credit line ratios for small and large firms strongly reject the hypothesis that there is no difference 
between these means. We observe that, on average, small and young firms have statistically 
significantly higher bank debt and term loan ratios than large and mature firms. In addition, the 
mean stock issue ratio shows that young and small firms’ reliance on stock issues is higher than in 
the case of mature and large firms, which is consistent with the literature (e.g., Brown et al., 
2012), and the t-tests for their means also support this finding. Further, young and small firms 
hold significantly more cash than do mature and large firms, which is consistent with the view that 
mature and large firms have relatively easy access to external capital markets. Consequently, they 
tend to hold less cash than small and young firms. 
[Insert Table 1c here] 
                                                     
19 Brown et al. (2012) use a similar classification.  
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5. Estimation results 
5.1. GMM estimation results 
Table 2 reports the system-GMM estimation results investigating the impact of bank debt 
and its components, including credit lines and term loans on R&D investment.20 In column (1), we 
run R&D investment regressions, controlling for Cash flow, Stock issues, Tobin’s Q, Sales growth, 
and ∆Cash. We also control for lagged R&D to account for the presence of the potential 
adjustment costs of R&D investments.      
Consistent with the results from Brown et al. (2012), we find that the coefficient for 
𝑅&𝐷𝑖,𝑡−1 is positive and statistically significant, while 𝑅&𝐷𝑖,𝑡−1
2  has negative and statistically 
significant coefficient estimates. These findings confirm that R&D investments are persistent and 
involve adjustment costs for our sample of European firms. The coefficients for Cash flowi,t and 
Stock issuesi,t are both positive and statistically significant, suggesting that European firms rely on 
internal financing and equity financing to fund their R&D investments.   
We also test whether the sum of coefficients for contemporaneous and lagged values of 
Cash flow and Stock issues is statistically significant.21 At the bottom of Table 2, we report the p-
values for the χ2 test with a null hypothesis that the sum of the current and lagged coefficients is 
equal to zero. Our results show that the p-value for the sum of Cash flowi,t and Cash flowi,t-1 is 
0.59, which implies that the long-term effect of cash flow on R&D investment is statistically 
                                                     
20 In our estimation, we employ ‘used’ credit lines rather than ‘unused’ credit lines, since ‘unused’ credit line data are 
not available for our full sample of firms, i.e., unused credit line data are available only for 477 firms out of our 
sample of 939 firms. When we regress R&D investment on unused credit lines, we find that the coefficient for unused 
credit lines is positive, but insignificant. As Campello et al. (2011) argue, the size of available credit lines may be a 
proxy for investment opportunities, and therefore, the credit line facilities themselves need not be used to finance the 
R&D spending.  Hence, used credit lines rather than unused credit lines can be more informative about the extent to 
which firms rely on their credit lines as a source of external financing for their R&D investments. However, our result 
of an insignificant coefficient for unused credit lines might not be reliable, since we lose more than 50% of the firm-
year observations when we employ unused (or available) credit lines in our regression model.  
21 The sum of the current and lagged values of these coefficients can be interpreted as the overall effect or long-term 
effect. We follow Bond et al. (2003) and interpret these sums as the long-term effects. 
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insignificant. This finding is consistent with the results from Bond et al. (2003) and Bhagat and 
Welch (1995). For stock issuance in column (1), we find that the p-value for the sum of 
𝑆𝑡𝑜𝑐𝑘 𝑖𝑠𝑠𝑢𝑒𝑠𝑖,𝑡 and 𝑆𝑡𝑜𝑐𝑘 𝑖𝑠𝑠𝑢𝑒𝑠𝑖,𝑡−1 is 0.20, which indicates that the long-term effect of stock 
issuance on R&D investment is positive, but statistically insignificant. We further observe that 
Sales growth does not have a statistically significant effect on R&D investment.  Consistent with 
the prior studies, we find that firms rely on their cash holdings as a source of financing their R&D 
investments. In column (1), the p-value for the sum of coefficients for ∆𝐶𝑎𝑠ℎ𝑖,𝑡 and ∆𝐶𝑎𝑠ℎ𝑖,𝑡−1 is 
0.02, which shows that cash holdings have a long-term effect on R&D investments. The negative 
coefficient on ∆𝐶𝑎𝑠ℎ shows that reductions in cash holdings provide liquidity for financing R&D 
investments. Our findings suggest that firms use cash holdings to smooth their R&D investments. 
This finding is consistent with Brown et al. (2012) and Brown and Petersen (2015).  
We also report the test statistic for testing second-order correlations in the first-differenced 
residuals. If there is a second-order correlation, this will make our GMM estimates inconsistent. 
Hansen’s J-test statistic is for testing over-identifying restrictions, while the difference-in-Hansen 
test statistic is for testing the validity of the additional differenced instruments required for 
systems estimation and is used in the levels equation. A low p-value for the J-test and difference-
in-Hansen test would indicate potential problems with instrument validity. Given these 
explanations, we confirm that our results pass the diagnostic tests, and hence, our instruments are 
valid.   
In columns (2) and (3), we add Leverage and Bank debt to our regression model, 
respectively.  We observe that in column (2) the sum of the leverage coefficients is near zero, and 
the p-value of 0.75 fails to reject the null hypothesis that the sum is zero. Further, in column (3), 
the sum of the bank debt coefficients is 0.011, but the p-value of 0.41 shows that the sum is again 
statistically insignificant, suggesting that bank debt is not used for financing R&D investments.   
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Next, we examine whether the components of bank debt, i.e., Used credit lines and Term 
loans, could have a significant effect on R&D investments. Previous studies have shown that 
credit lines could provide liquidity insurance and act as a substitute for cash holdings. Hence, we 
expect that firms facing high adjustment costs of R&D investments can rely on credit lines as a 
way of managing their liquidity to maintain a smooth R&D profile. In column (4), we observe that 
the contemporaneous coefficient for used credit lines (0.096) is positive and significant. A one-
standard deviation increase in the ratio of used credit lines-to-total assets is associated with a 
65.64 basis point increase in the ratio of R&D-to-total assets, showing that our finding is also 
economically significant. Further, the sum of coefficients for the lagged and contemporaneous 
value of Used credit lines is 0.05 and is statistically significant (p-value of 0.04).  For Term loan in 
column (5), the sum of the coefficients is -0.006, and it is statistically insignificant (p-value = 
0.64). Our findings suggest that even if leverage or bank debt does not have any significant effect 
on R&D investments, once the debt structure is decomposed, used credit lines as a component of 
bank debt is a significant determinant of the R&D investments of European firms. We can 
interpret this finding as firms using credit lines as a tool for liquidity management (e.g., Sufi, 
2009; Acharya et al., 2013).  They can draw on their credit lines and smooth their R&D 
investments, reducing their adjustment costs.22 Thus, credit lines, which are more flexible than 
term loans, could provide firms with liquidity insurance. In column (6), we include both Term 
loans and Used credit lines as components of bank financing, and we still find that the impact of 
used credit lines on R&D investment is positive and statistically significant (p-value =0.02). 
                                                     
22 We also analysed the effect of used credit lines on capital expenditures, but could not find a significant effect. 
Given that R&D investments are likely to have relatively high adjustment costs, compared to capital expenditures 
(e.g., Brown et al., 2012), firms would be expected to rely on credit lines as liquidity insurance to smooth their R&D 
investments rather than physical investment.  
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However, the sum of coefficient estimates for the lagged and contemporaneous value of Term 
loans is again statistically insignificant (p-value =0.96).  
 [Insert Table 2 here] 
5.2. Sample splits for financially constrained and unconstrained firms 
In this subsection, we investigate whether there are differences between financially 
constrained and unconstrained firms in terms of their reliance on credit lines as a source of 
financing for their R&D investments. There has been a debate about the relative merits of various 
methods for measuring financial constraints. Firm age and firm size are commonly used as proxies 
for measuring whether a firm is financially constrained or unconstrained.  Previous researchers 
have argued that firm size and firm age appear to be closely related to financial constraints, and 
they are much less endogenous than most other sorting variables (e.g., Farre-Mensa and 
Ljungqvist, 2016; Hadlock and Pierce, 2010). Thus, in our analysis, we follow the recent extant 
literature and use firm age and firm size as our proxies for measuring financial constraints.23 
In Table 3, we classify our sample of firms into groups of young, mature, small and large 
firms. We expect a stronger relation between R&D investment and used credit lines in the groups 
of young and small firms. As Table 1c reveals, on average, small and young firms have a higher 
ratio of R&D than large and mature firms. These firms are more likely to experience liquidity 
shortages, and are thus more likely to require more liquidity insurance to smooth their R&D 
investments. Since credit lines can provide firms with liquidity insurance, young and small firms 
can rely more on credit lines than mature and large firms. 
[Insert Table 3 here] 
                                                     
23 Additionally, we use the dividend payout ratio, the HP (Hadlock-Pierce) index, and the KZ (Kaplan-Zingales) index 
as alternative measures for classifying our sample of firms into financially constrained and unconstrained groups. Our 
results remain the same. For brevity, we do not tabulate these results. 
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Table 3 reports the GMM estimation results for our subsamples of financially constrained 
firms, i.e., young and small firms, and financially unconstrained firms, i.e., mature and large firms. 
The coefficient estimates for R&Dt-1, for both financially constrained and unconstrained groups, 
are close to 1, showing that R&D investment is persistent. The coefficient for R&D2t-1 for 
financially unconstrained firms is smaller than that for constrained firms, suggesting that the 
financially constrained firms’ adjustment costs of R&D are less than those of unconstrained firms. 
The sums of coefficients for used credit lines are positive and statistically significant for the young 
and small firms (columns 1 and 3). However, the sums of used credit line coefficients for mature 
and large firms are statistically insignificant. These findings support our expectation that 
financially constrained firms are more likely to use credit lines for financing their R&D 
investments. The sum of the Cash flow coefficients is positive and statistically significant for large 
firms (p-value = 0.01), consistent with the literature (Hall, 2002), while the sum of the Stock issues 
coefficients is positive and statistically insignificant (p-value =0.12) for mature firms. Further, for 
young and small firms, only the coefficient on lagged cash holdings is statistically significant, 
while for mature and large firms, both the lagged cash holdings and the sum of lagged and 
contemporaneous cash holdings are statistically significant. These results suggest that cash 
holdings affect young and small firms’ R&D investments only in the short term, while this effect 
exists both in the short and long term for mature and large firms.  
 
5.3. Sample splits for high and low R&D firms and alternative sources of financing 
In this section, we classify our sample into high and low R&D subgroups to explore 
whether we observe any differences between these subgroups in terms of relying on credit lines 
for financing R&D activities. Firms with a ratio of R&D investment above (below) the sample 
median are classified into high (low) R&D subgroups. If credit lines provide liquidity insurance 
for firms to smooth their R&D investments, which involve high adjustment costs, then we would 
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expect to see a stronger impact of credit lines on R&D investment for the subgroup of firms with 
high R&D in column (2) than firms with low R&D in column (1) of Table 4. Our findings in 
columns (1) and (2) support this prediction. The sum of the coefficient estimates for used credit 
lines in column (1) is positive and statistically insignificant, while it is positive and statistically 
significant in column (2). Thus, firms with high R&D rely on credit lines more than those with 
low R&D as a source of financing.  
 In column (3) and column (4) of Table 4, we examine whether there are differences 
between high and low cash holding groups of firms with high R&D. High R&D firms with a ratio 
of cash holdings above (below) the sample median are classified into high R&D and high (low) 
cash holding groups. Firms with high R&D and high cash holdings are more likely to use their 
internal financing rather than credit lines, which could involve monitoring from lenders.  
However, firms with high R&D and low cash holdings would use credit lines, as they lack 
alternative sources of internal financing.  Our results in column (3) and (4) support this prediction.  
In column (3), the sum of the coefficient estimates for used credit lines is positive and significant, 
while there is no statistically significant impact of used credit lines on R&D investment in the 
subgroup of firms with high R&D and high cash in column (4).  
 Next, in columns (5) and (6), we classify our sample into subgroups of firms with high 
R&D and high stock issuances, and those with high R&D, but low stock issuances. High R&D 
firms with a ratio of stock issuances-to-total assets above (below) the sample median are classified 
into high R&D and high (low) stock issuance groups. As a further test of whether access to 
alternative sources of financing influences firms’ use of credit lines in funding their R&D 
investments, we examine whether firms with access to equity financing would rely less on credit 
lines as a source of financing, since they would not prefer to expose themselves to monitoring by 
lenders.  Our results in Table 4 show that firms with high R&D and low stock issuances, i.e., 
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column (5), use credit lines as source of funding their R&D activities, but we do not observe a 
similar significant impact of credit lines for firms in column (6).  
In columns (7) and (8), we focus on subgroups of firms with high R&D and low cash 
flows, and firms with high R&D and high cash flows. High R&D firms with a ratio of cash flows-
to-total assets above (below) the sample median are classified into high R&D and high (low) cash 
flow groups. Sufi (2009) argues that credit lines, which provide firms with liquidity insurance, are 
accessible for firms with high cash flows, as such firms are more likely to fulfill the covenant 
requirements than those with low cash flows. We would therefore expect those firms in column 
(8) to have a stronger relationship between used credit lines and R&D investments than firms in 
column (7), which have high R&D and low cash flows. Consistent with this expectation, we 
observe that in column (8) the sum of the coefficient estimates for Used credit lines is positive and 
statistically significant, while we do not observe a significant relationship between used credit 
lines and R&D investments in column (7). Overall, these results provide further evidence that 
firms use credit lines to fund their R&D investments when their access to alternative sources of 
funding is limited.24 
[Insert Table 4] 
5.4. Difference-in-differences estimation results: The 2007-2009 financial crisis and European 
sovereign debt crisis  
The 2007-2009 financial crisis has been viewed as an external shock for European firms, 
and several studies have investigated its impact on corporate financial policies (see, for instance, 
                                                     
24 We also considered whether firms with access to public debt markets would still use credit lines for financing their 
R&D investments.  Following Faulkender and Petersen (2006), we use a corporate credit rating by the S&P as a 
measure of whether firms have access to public debt. We collected S&P ratings data from Thomson Reuters EIKON. 
In untabulated results, we find that our sample of European firms with public debt access (approximately 10% of our 
sample firms) use credit lines for financing their R&D investments similar to those firms with no public debt access. 
For brevity, we do not report these findings. 
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Campello et al., 2012; Beuselinck et al., 2017; Gilchrist and Mojon, 2017). Table 5 reports 
difference-in-differences estimation results for R&D investments. For brevity, we report only the 
coefficient estimates for Used credit lines, ∆Cash and their interaction variables with the crisis 
dummies. We test whether firms’ use of credit lines and cash reserves for financing their R&D 
investments changed during the 2007-2009 crisis and the European sovereign debt crisis period. 
Following previous studies, we create a dummy variable, Crisis, which is equal to 1 if a year is 
between the 2007-2009 period, and 0 otherwise (e.g., Beuselinck et al., 2017). Additionally, we 
define another Crisis dummy for the sovereign debt crisis period. Previous researchers have 
argued that the European sovereign debt crisis period started in 2010 and still continues (e.g., 
Gilchrist and Mojon, 2017). We follow the literature and define the European sovereign debt crisis 
period as 2010 and following years in our sample, i.e., 2010-2013. Next, we interact our crisis 
dummy variables with cash holdings and used credit lines to investigate whether firms continued 
to rely on their cash holdings and credit lines during the crisis period. As documented by prior 
studies, the 2007-2009 crisis and European sovereign debt crisis differ in terms of a substantial 
decline in the corporate lending of European banks during the European sovereign debt crisis 
(e.g., Becker and Ivashina, 2016). 
[Insert Table 5 here] 
 In column (1), we test the impact of used credit lines on R&D investment during the 
financial crisis of 2007-2009. Firms can rely more on their credit lines if their access to external 
capital markets becomes relatively more limited. However, their use of credit lines during a time 
of crisis will depend on the financial health of the banks. As long as banks can fulfill their 
commitment for credit line contracts, firms can continue to rely on credit lines (or can possibly 
increase their use of credit lines) for financing their R&D investments during a time of crisis. We 
find that the sum of the coefficients for Used credit lines*Crisis is negative and statistically 
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insignificant, while it is positive and statistically significant for Used credit lines only. Thus, we 
do not observe any significant difference between the crisis and non-crisis periods in terms of how 
used credit lines influence R&D investments. Overall, credit lines have a positive impact on R&D 
investments, and firms seem to continue to rely on credit lines during the crisis period as a way of 
financing their R&D investments. Our findings are consistent with Campello et al. (2012)’s survey 
showing that European firms extensively used their credit lines during the financial crisis.   
Moreover, our analysis supports previous studies, which have argued that the European 
banking system is more of a relationship-based system when compared to the system in the US.25 
Recently, Bolton et al. (2016) have used credit registry data for a sample of Italian firms to 
differentiate between relationship and transactional lending. They document that relationship 
banking plays an important role in dampening the impact of a negative exogenous shock, i.e., 
financial crisis.  Their results show that firms relying on relationship lending can weather crises 
better, as they continue to borrow from their banks on favorable terms.26 In column (2), we 
observe the coefficients for the current and lagged values of ∆Cash*Crisis, and their sum is 
positive, but statistically insignificant. Thus, our results suggest that the impact of cash holdings 
on R&D investments does not change during the crisis period, compared to the non-crisis period. 
 In columns (3) and (4), we investigate the effect of the European sovereign debt crisis on 
the financing of R&D investments. We test whether the use of credit lines and cash reserves for 
                                                     
25 We also run regressions using US data and find that credit lines (or term loans) do not exert any statistically 
significant influence on R&D investments. This finding is in line with arguments that the US banking system is 
relatively less relation-based than the European banking system. See, for instance, Ongena and Smith (2000) and 
Detragiache et al. (2000). Additionally, Berg et al. (2017) show that large and rated European firms obtain 45% of 
their debt financing from bond markets, while the percentage for large and rated US firms is over 75%. For brevity, 
we do not tabulate our R&D regression results for US firms.  
26 For our sample of firms, we do not have access to detailed credit registry data, which would allow us to examine 
how bank-firm relationships changed throughout the crisis and non-crisis periods. We checked the Dealscan database, 
which provides characteristics of syndicated loan contracts. This dataset is available only for 248 firms of our sample 
of 939 firms. Table A4 in the Appendix shows that the cost of debt increased more for term loans than for credit lines 
during the crisis period, which could partly explain why firms rely on credit lines rather than term loans for financing 
their R&D investments. 
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R&D investments differ between the European sovereign debt crisis period and before this period. 
In column (3), we interact Crisis with Used credit lines to investigate whether firms continued to 
rely on credit lines during the sovereign debt crisis period when access to external financing 
sources is limited. We find that the sum of the coefficients for Used credit lines*Crisis  is negative 
and statistically insignificant, but it is positive and statistically significant for Used credit lines. 
Hence, in terms of how credit lines influence R&D investments, we do not observe any significant 
difference between the European sovereign debt crisis and the pre-crisis periods. Overall, our 
findings suggest that firms continued to rely on credit lines during the European sovereign debt 
crisis period as a way of financing their R&D investments.27  
In column (4), we add both ∆Cash*Crisis and Used credit lines*Crisis interaction terms to 
our regression model. We find that the coefficient estimate for ∆Cashi,t-1 is -0.026, while it is -
0.091 for ∆Cashi,t-1*Crisis. These coefficients are statistically significant at the 5% and 1% levels, 
respectively. These findings suggest that the impact of cash holdings on R&D investments 
increased during the sovereign debt crisis, showing that firms’ reliance on cash was higher during 
the sovereign debt crisis. Further, our results are consistent with the literature, documenting that 
during the sovereign debt crisis in Europe, firms’ access to external finance became more limited, 
i.e., the cost of debt (spread) increased during this period (e.g., Gilchrist and Mojon, 2017). 
Therefore, as expected, firms relied more on cash reserves for financing their R&D investments 
during the European sovereign debt crisis. Further, we observe that the sum of the current and 
lagged coefficients for ∆Cash*Crisis is negative, but statistically insignificant (p-value =0.29). 
Hence, we could not find statistically significant long-term effect of cash holdings on R&D 
investments during the sovereign debt crisis. More importantly, our results show that the sum of 
                                                     
27 France, the UK and Germany were relatively less affected countries by the sovereign debt crisis (Acharya et al., 
2016). Hence, we conducted the same analysis by excluding the UK, Germany, and France. Unreported results from 
this analysis are still consistent, showing that the findings are not driven by firms from these countries.  
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the lagged and current coefficients for Used credit lines is positive and significant (p-value =0.02), 
while this coefficient for Used credit lines*Crisis is negative and statistically insignificant (p-
value =0.69), suggesting that used credit lines provided financing for R&D investments in both the 
European sovereign debt crisis and before this debt crisis period. 
   
5.6. Financially constrained firms and financial crises 
 In this subsection, we investigate whether financially constrained firms use more credit 
lines during crisis times when it would normally be more difficult to raise financing externally. 
Given that R&D investments mainly involve the salaries of scientists and employees with high 
firm-specific human capital, firms would have the priority to protect their R&D investments 
during a crisis period (Brown and Petersen, 2015).  If they fire their employees during a crisis, it 
would be considerably difficult to hire new employees with a similar level of firm-specific human 
capital, which could lead to major productivity losses. Costly hiring and firing of these highly 
skilled employees create high adjustment costs for R&D investments. Hence, firms strategically 
try to maintain a smooth path of R&D investment in order to reduce their R&D adjustment costs 
(Brown and Petersen, 2011). 
As long as creditors can honor their commitment for firms’ existing credit lines, firms with 
more limited access to alternative sources of financing can draw funds from their existing credit 
lines and can finance their R&D investments. Table 6 presents our estimation results with the 
crisis interaction dummies, i.e., the financial crisis 2007-2009 dummy and the European sovereign 
debt crisis dummy. For brevity, we do not report the coefficient estimates for firm-level control 
variables, as shown in Equation (1). Our findings in columns (1), (3), (5) and (7) show that 
financially constrained firms continued to use credit lines as a source of financing during both 
crises.  However, they did not seem to increase their use of credit lines for financing their R&D 
investments during the crises (i.e., none of the p-values for Used credit lines*Crisis are 
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significant). This might be due to supply- or demand-driven effects. As we do not have detailed 
firm-bank level credit registry data, we cannot examine how the bank-firm relationship evolved 
throughout the crisis and non-crisis periods.  However, our results are consistent with the view 
that relationship banking in Europe can help firms relieve their financial constraints during a time 
of crisis.   
For financially unconstrained firms in columns (2), (4), (6) and (8), we observe that the 
sum of the coefficient estimates for Used credit lines*Crisis is not statistically significant. Thus, 
we do not observe any significant difference in these firms’ use of credit lines for financing their 
R&D investments between crisis and non-crisis periods. Further, we observe that the sum of the 
coefficient estimates for ∆Cash is negative and statistically significant, while the sum of the 
coefficient estimates for ∆Cash*Crisis is statistically insignificant.  This finding shows that 
financially unconstrained firms continued to rely on their cash holdings during the crisis periods.   
 [Insert Table 6]  
5.7. Additional Tests 
5.7.1. R&D investments and credit lines in bank-based countries 
In this subsection, we test whether the link between R&D investments and used credit lines 
vary, depending on the level of credit market development relative to the level of stock market 
development, i.e., bank-based versus market-based financial structures.28 As Brown et al. (2012) 
argue, European countries vary considerably in their stock market development and credit market 
development, which could have implications for firms’ financing patterns.  Following Demirguc-
Kunt and Levine (2001) and Didier et al. (2014), we use the ratio of credit market development to 
                                                     
28 Prior studies have emphasized the importance of financial development, i.e., stock market development and credit 
market development, in determining innovation and R&D investments. Using a cross-country sample, Hsu et al. 
(2014) report that stock market development has a positive impact on innovation, while credit market development 
discourages innovation. Additionally, Brown et al. (2013) find that access to equity financing through well-developed 
stock markets increases R&D investments for a sample of firms from 32 countries. In contrast, their results show that 
credit market development has no significant impact on R&D investments.   
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stock market development and classify our sample of European countries into groups of bank-
based and market-based financial systems. Countries with an average ratio of credit market 
development to stock market development above the median are classified into the group of bank-
based countries, while those below the median are classified into the group of market-based 
countries. To classify the countries, we use the data for credit market development and stock 
market development for 2006, which is the year before the 2007-2009 financial crisis, given that 
crises may affect the values of these variables. Alternatively, using the average values of credit 
market development and stock market development over the period 2004-2006 rather than 2006 
yields the same classification. Based on this classification, we have Austria, Denmark, Germany, 
Ireland, Italy, the Netherlands, Norway, and Spain in the group of countries with the bank-based 
financial system, while Belgium, Finland, France, Greece, Poland, Sweden, Switzerland, Turkey, 
and the UK are classified into the group of countries with the market-based financial system. 
 Relationship banking is likely to be more prevalent in countries with the bank-based 
financial system, as banks in these countries have more opportunities to obtain proprietary 
borrower information through repeated interaction with borrowers (Beck et al., 2017).  Bolton et 
al. (2016) provide evidence that relationship banking may have played an important role in 
dampening the effects of negative shocks of the 2007-2009 crisis on Italian firms.29 They find that 
Italian firms relying on relationship banks were less likely to default on their loans and could 
withstand the 2007-2009 crisis better, since their relationship banks continued to lend to them on 
favorable terms. Our sample of firms from bank-based countries can benefit from relationship 
lending, which can help them protect their R&D investments during a period of exogenous shock.  
Hence, these firms can increase their use of credit lines during a financial crisis relatively more 
                                                     
29 Relationship banks accumulate valuable information during the lending relationship and can more easily adjust their 
lending terms to changing economic circumstances (e.g., Beck et al., 2017; Puri et al., 2011; Jiménez et al., 2016). 
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than firms in market-based countries. However, the increase in their use of credit lines will be 
limited to the extent that banks are able to fulfill their commitments.   
In our dynamic regression model, we interact used credit lines with a crisis dummy and a 
dummy for bank-based countries to investigate whether firms in bank-based countries rely more 
on credit lines during a period when access to alternative sources of financing becomes more 
limited. Table 7a reports the estimation results for our regression model, which incorporates the 
dummy for bank-based countries. In column (1), we observe that the coefficient estimate in the 
case of the dummy for bank-based countries is negative and statistically significant. This finding 
is consistent with results from Hsu et al. (2014), showing that credit market development does not 
encourage innovation. Further, we observe that the sum of the coefficient estimates for Used 
credit lines is statistically insignificant, while the sum of the coefficients for Used credit 
lines*Bank-based is positive and significant. Thus, our results show that firms in bank-based 
countries rely on credit lines to finance their R&D investments, contrary to those firms in market-
based countries. In column (2), we observe that the sum of the coefficient estimates for Used 
credit lines*Crisis*Bank-based is positive and statistically significant (p-value =0.09). This result 
indicates that firms in bank-based countries increased their use of credit lines as a source of 
financing for R&D investments during the 2007-2009 crisis.  However, in column (3) we observe 
that the sum of the coefficient estimates for Used credit lines*Crisis*Bank-based is negative and 
statistically significant (p-value =0.05). Thus, firms in bank-based countries reduced their use of 
credit lines for funding their R&D investments in the case of the sovereign debt crisis. This result 
is consistent with findings from prior studies, which show that bank lending declined considerably 
during the European sovereign debt crisis (e.g., Becker and Ivashina, 2016).  Further, in columns 
(2) and (3), the sum of the coefficient estimates for Used credit lines*Crisis is statistically 
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insignificant, indicating that firms in market-based countries did not change their use of credit 
lines during the crisis periods.   
Overall, we find that the association between used credit lines and R&D investments varies 
among firms, depending on whether they are in a bank-based or market-based country. More 
importantly, the effects of the 2007-2009 crisis and the European sovereign debt crisis on the link 
between R&D investments and used credit lines seem to be different in bank-based countries, 
compared to those in market-based countries. 
[Insert Table 7a here] 
In Table 7b, we first split our sample into groups of young, mature, small, and large firms, 
as in section 5.2. We then interact Crisis and Bank-based dummy variables with Used credit lines 
to investigate whether young and small firms in bank-based countries rely more on credit lines to 
protect their R&D investments during a crisis. Columns (1) to (4) show that the sum of the 
coefficient estimates for Used credit lines*Crisis* Bank-based is positive and significant only for 
young and small firms. The sum of the coefficient estimates for Used credit lines*Crisis, however, 
is negative and insignificant for all subgroups of firms, regardless of their firm age and firm size.  
These findings suggest that only young and small firms in bank-based countries increased their 
use of credit lines to finance their R&D investments during the 2007-2009 financial crisis. We 
could not find similar results for the young and small firms in market-based countries.  These 
findings are consistent with the view that relationship banking, which can help firms weather 
crises relatively more easily, is likely to be more prevalent in bank-based countries  
Next, in Panel B of Table 7b, we investigate the effect of the European sovereign debt 
crisis on the relationship between used credit lines and R&D investments for financially 
constrained (small and young) firms and unconstrained firms (large and mature). Columns (5) to 
(8) show that the sum of the coefficient estimates for Used credit lines*Crisis*Bank-based is 
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negative and significant only for young and small firms. However, the sum of the coefficient 
estimates for Used credit lines*Crisis is statistically insignificant in all columns. These results 
suggest that young and small firms in bank-based countries reduced their use of credit lines for 
R&D investments during the European sovereign debt crisis period. In columns (6) and (8) the 
sum of the coefficient estimates for Used credit lines*Crisis*Bank-based is statistically 
insignificant.  This finding shows that mature firms and larger firms, different from young and 
small firms, do not change their use of credit lines for financing their R&D investment in bank-
based countries. 
Overall, our findings in Table 7b reveal that only young and small firms in bank-based 
countries, but not those in market-based countries, increased their reliance on credit lines for 
financing their R&D investments during the 2007-2009 financial. Conversely, the same group of 
firms decreased their use of credit lines during the European sovereign debt crisis. This finding is 
consistent with prior studies, which document that relative to the 2007-2009 financial crisis, the 
European sovereign debt crisis has had a substantially more adverse impact on the corporate 
lending of European banks (e.g., Becker and Ivashina, 2016). 
[Insert Table 7b here] 
5.7.2. Sample split between the UK and continental Europe 
In this section, we investigate whether our results are robust and not driven by the sub-
sample of UK firms, which constitutes a large part of our sample. In Table 8, we estimate our 
model, excluding the UK firms. We observe that the sum of the Used credit lines coefficients is 
positive and statistically significant (p-value = 0.08), as in our full sample. The sum of cash 
holding coefficients (∆Cash) is also significant. Moreover, the sum of the coefficients for Cash 
flow and Stock issues is not significant, as it was the case for our whole sample. This table 
documents that excluding the UK does not change our main result, which suggests that used credit 
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lines have a positive impact on R&D investments. Overall, Table 8 shows that our results are not 
driven by the dominance of the UK subsample, and the findings remain qualitatively very similar 
if we exclude the UK firms from our sample. 
[Insert Table 8 here] 
 
6. Conclusion 
   This paper examines the impact of bank debt and its components, i.e., term loans and 
credit lines, on R&D investments for a sample of European firms over the period 2004 to 2013. 
We find that bank debt and term loans do not have a significant impact on R&D investments, 
while there is a significant and positive relationship between used credit lines and R&D 
investments. Additionally, we observe that the effect of used credit lines on R&D investments is 
relatively stronger for financially constrained firms, i.e., small and young firms, than for 
financially unconstrained firms, i.e., large and mature firms, suggesting that firms with limited 
access to external capital markets use credit lines as a source of financing their R&D investments.   
Further, our results show that firms continued to rely on credit lines to fund their R&D 
investments during the crisis periods, i.e., the 2007-2009 financial crisis and the Euro area 
sovereign debt crisis, when access to alternative sources of financing became more limited. 
However, when we classify our sample of European countries into groups of bank-based and 
market based countries, we find that European firms in bank-based countries increased their use of 
credit lines for financing their R&D investments during the financial crisis of 2007-2009, while 
the link between R&D investments and used credit lines becomes weaker during the European 
sovereign debt crisis of 2010-2013. 
Overall, our findings provide supporting evidence for the role of banks in shaping R&D 
investment decisions by showing that firms rely on credit lines as a source of financing for their 
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R&D investments.  Our results also complement the findings from previous studies showing that 
credit lines could be important as a liquidity management tool, particularly for those firms that 
have relatively more limited access to external capital markets.  Further, our results offer new 
insights on why R&D investments have been considerably stable during financial crises.  Our 
sample of European firms has been able to rely on credit lines, as well as cash holdings, to smooth 
their R&D investments during periods when access to external capital markets becomes relatively 
more limited. Finally, our results suggest that banks can influence R&D investments in Europe 
and can play a role in determining firms’ responses to financial crises.   
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Appendix 
 
Table A1  
Variable  definitions. 
Variable Definition 
R&D Research and development expenses (WC01201)/Total assetsi,t-1 (WC02999).  
Source: Worldscope 
 
Cash flow Net income (WC01551) + Depreciation (WC01148) +  R&D (WC01201))/Total assetsi,t-1 
(WC02999).  Source: Worldscope 
 
Stock issues (The received amount from the sale of common and/or preferred stocks less repurchases 
(WC04251-WC04751))/Total assetsi,t-1 (WC02999).  Source: Worldscope 
Tobin's Q  
Total assets (WC02999) + Market value of equity (WC08001) less book value of equity 
(WC03501)/ Total assetsi, t-1 (WC02999). Market and book value of equities are adjusted for 
their fiscal year-end.   Source: Worldscope 
   
Sales growth (Net salesi,t – Net salesi,t-1)/Net salesi,t-1.  Net sales are gross sales and other operating revenue - 
discounts, returns and allowances (WC01001).  Source: Worldscope 
 
Cash  
 
Cash & short term investments (WC02005)/Total assetsi,t-1 (WC02999).  Source: Worldscope 
 
Employee Number of employees (WC07011).  Source: Worldscope 
 
Total assets Sum of total current assets, long-term receivables, investment in unconsolidated subsidiaries, 
other investments, net property plant and equipment and other assets (WC02999).   
Source: Worldscope 
 
Leverage Total debt (WC03255) /Total assetsi,t-1 (WC02999).  Source: Worldscope 
 
Bank debt (Credit lines+ Term Loan)/Total assetsi,t-1 (WC02999).  Source: Capital IQ 
 
Used credit lines Drawn credit lines/Total assetsi,t-1 (WC02999).  Source: Capital IQ 
 
Unused credit lines Undrawn credit lines/Total assetsi,t-1 (WC02999).  Source: Capital IQ 
 
Term loans Term Loans/Total assetsi,t-1 (WC02999).  Source: Capital IQ 
  
Credit market development Lending from domestic banks to the private non-financial sectors as a proportion of GDP (%).  
Source: Lending data are from the Bank for International Settlements (BIS).  GDP data (at 
current and non-adjusted prices) are from International Financial Statistics or World Economic 
Outlook, IMF.  
 
Stock market development 
 
Stock market capitalization to GDP (%). Source: World Bank. 
 
Bank-based A country-level binary variable that is 1 if the ratio of Credit Market Development to Stock 
Market Development is higher than the sample median, and 0 otherwise. To classify the 
countries, we use the data from 2006, a year before the recent financial crisis, since crises may 
affect the values. Using the data from 2004-2006 rather than 2006 provides the same 
classification. A similar approach is used in Didier et al. (2014).  This construct shows that our 
sample of bank-based countries are Austria, Denmark, Germany, Ireland, Italy, the Netherlands, 
Norway, Spain, while market-based countries are Belgium, Finland, France, Greece, Poland, 
Sweden, Switzerland, Turkey and the UK.  
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    Table A2 
     Sample distribution across countries and descriptive statistics for country-specific characteristics.  
 
 
 
Number 
(%) of firms 
 
 
Number 
of firm-years 
Stock market 
development 
Credit market 
development 
Credit market 
development/Stock 
market 
development 
   Mean Mean Mean  
   [Median] [Median] [Median] 
Austria 24 (2.56) 97 0.346 0.948 2.740 
   [0.301] [0.944] [3.136] 
Belgium 24 (2.56) 92 0.603 0.594 0.985 
   [0.570] [0.577] [1.012] 
Denmark 31 (3.3) 113 0.647 1.641 2.536 
   [0.624] [1.648] [2.641] 
Finland 62 (6.6) 297 0.787 0.869 1.104 
   [0.572] [0.875] [1.530] 
France 74 (7.88) 366 0.737 0.982 1.332 
   [0.720] [1.024] [1.422] 
Germany 159 (16.93) 706 0.428 0.816 1.907 
   [0.418] [0.859] [2.055] 
Greece 11 (1.17) 37 0.354 0.900 2.542 
   [0.295] [0.915] [3.102] 
Ireland 12 (1.28) 46 0.437 1.381 3.160 
   [0.468] [1.351] [2.887] 
Italy 25 (2.66) 114 0.345 0.831 2.409 
   [0.354] [0.821] [2.319] 
Netherlands 40 (4.26) 174 0.796 1.161 1.459 
   [0.767] [1.162] [1.515] 
Norway 23 (2.45) 81 0.576 0.802 1.392 
   [0.550] [0.837] [1.522] 
Poland 5 (0.53) 10 0.324 0.455 1.404 
   [0.320] [0.474] [1.481] 
Spain 9 (0.96) 32 0.869 1.536 1.768 
   [0.882] [1.596] [1.810] 
Sweden 84 (8.95) 327 1.005 1.166 1.160 
   [0.995] [1.243] [1.249] 
Switzerland 61 (6.5) 345 2.010 1.488 0.740 
   [2.039] [1.497] [0.734] 
Turkey 36 (3.83) 155 0.313 0.424 1.355 
   [0.304] [0.413] [1.359] 
UK 259 (27.58) 1,254 1.155 1.026 0.888 
   [1.187] [1.020] [0.859] 
All countries 939 (100) 4,246 0.894 1.009 1.129 
   [0.888] [0.988] [1.113] 
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Table A3  
Descriptive statistics for debt components (Debt types/Total debt). 
All debt variables are scaled by total debt. Our sample consists of 939 firms from 17 European countries 
over the period 2004-2013. Panel A reports average values of debt variables over the period 2004-2013, 
while Panel B reports average values of debt variables for each year from 2004 to 2013. 
Panel A. Full sample 
 Bank debt 
Used  
credit lines 
Term loans 
Mean 0.288 0.042 0.245 
Median 0.270 0.038 0.229 
No. of observations 4,231 4,243 4,222 
No. of firms 939 939 939 
 
Panel B. Descriptive statistics by year 
Year N Bank debt 
Used  
credit lines 
Term loans 
2004 80 0.160 0.028 0.132 
2005 337 0.256 0.026 0.229 
2006 476 0.270 0.045 0.224 
2007 495 0.342 0.047 0.296 
2008 507 0.395 0.079 0.315 
2009 527 0.286 0.035 0.250 
2010 504 0.271 0.024 0.247 
2011 483 0.264 0.048 0.216 
2012 455 0.257 0.038 0.219 
2013 377 0.238 0.031 0.206 
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Table A4 
Descriptive statistics for characteristics of new credit lines and term loans. 
This table reports descriptive statistics for the characteristics of new credit lines and term loans from 2004 to 2012. The Dealscan 
data for the year 2013 are not available. We merge our sample of 939 firms from 17 European countries, which are covered by 
Worldscope and Capital IQ, with loan contract data from the Dealscan database. In column (1), we report the number of new 
credit lines and term loan facilities from the deals between firms and banks. Each package can have more than one debt type. In 
columns (2) and (3), the cost of debt is in basis points (bps) and includes the fees borrowers pay over LIBOR for each dollar 
drawn down.  
We have loan contract data available for 248 of our sample firms. We observe that the number of credit lines (term loans) is 43(19) 
in 2006, while it is 51(46) in 2009. Thus, there is no decline in the number of new credit lines (term loans) during the financial 
crisis period 2007-2009. However, the table shows that there is a considerable increase in fees for new credit lines (term loans) 
from 2006 to 2009. We observe that the average fee for new credit lines (term loans) moves from 61.2 (69.3) bps in 2006 to 238.3 
(335.0) bps in 2009. The average (median) fees for new credit lines and terms loans decline from 2009 to 2012. As previous 
studies have shown, loan contracts have option-like characteristics (Berg et al., 2016; Thakor et al., 1981). For instance, a 
borrowing firm can exercise the option of drawing down on a line of credit when the committed interest rate is relatively lower 
than the spot market rate. Thus, fees for credit lines can be viewed as a proxy for measuring the price for options embedded in 
credit line contracts. Further, fees provide a way of screening, based on whether they have private information about exercising 
the options in loan contracts. We observe that the average size of new credit lines (term loans) provided by banks declines from 
$1.717 billion ($1.718 billion) in 2006 to $600 ($258) million in 2009. We further observe that there is an increase (decrease) in 
the average maturity of new credit lines (term loans) from 2009 onward. 
 
Number of 
new credit 
lines (new 
term loans)                                     
Cost of debt 
for credit 
lines: 
mean 
(median)  
Cost of debt 
for term 
loans: 
mean 
(median)  
Amount of 
new credit 
lines, in 
million $: 
mean 
(median)  
Amount of 
new term 
loans, in 
million $: 
mean 
(median)  
Maturities for 
credit lines, in 
months: 
mean 
(median)  
Maturities for 
term loans, in 
months: 
mean 
(median)  
Year (1) (2) (3) (4) (5) (6) (7) 
2004 32 (7) 59.7 (33) 118.3 (40) 2,036 (936) 330 (150) 56.7 (60) 47.0 (36) 
2005 73 (23) 36.5 (25) 124.5 (70) 1,737 (837) 1,036 (189) 66.3 (60) 63.7 (60) 
2006 43 (19) 61.2 (37) 69.3 (45) 1,717 (856) 1,718 (447) 61.1 (60) 83.3 (60) 
2007 50 (25) 70.5 (26) 100.6 (71) 1,437 (641) 2,587 (433) 65.0 (60) 71.3 (60) 
2008 44 (36) 83.0 (70) 105.8 (80) 873 (603) 1,172 (547) 44.3 (36) 75.0 (57.5) 
2009 51 (46) 238.3 (250) 335.0 (308) 600 (352) 258 (114) 38.9 (36) 69.6 (36) 
2010 59 (26) 186.6 (146) 206.3 (220) 968 (485) 865 (250) 50.4 (50) 57.2 (45) 
2011 87 (25) 120.1 (93) 249.3 (275) 1,208 (553) 599 (371) 55.5 (60) 51.9 (42) 
2012 25 (8) 145.2 (85) 232.0 (300) 1,035 (603) 832 (286) 57.4 (60) 28.1 (27) 
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Table 1a 
Descriptive statistics for debt-related variables (Debt/Lagged total assets). 
This table reports descriptive statistics for debt-related variables, which are scaled by beginning of the year total assets. Our 
sample of firms comes from 17 major European countries covered by Worldscope and Capital IQ over the period 2004-
2013. Panel A reports average values of debt-related variables for the whole period, while Panel B reports average values 
of debt-related variables for each year. Unused credit lines data are available only for 477 firms out of our sample of 939 
firms. Thus, we do not include it as a variable in our main regression analyses, but we provide descriptive statistics here for 
comparison purposes. 
Panel A. Full sample 
 Leverage Bank debt 
Used 
credit lines 
Unused  
credit lines  
Term loans 
Mean 0.235 0.154 0.036 0.139 0.117 
Median 0.210 0.115 0.000 0.117 0.065 
Standard deviation 0.167 0.149 0.068 0.103 0.143 
No. of observations  4,238 4,238 4,246 1,818 4,231 
No. of firms 939 939 939 477 939 
 Panel B. Descriptive statistics by year 
Year N Leverage Bank debt 
Used 
credit lines 
Unused 
credit lines 
Term loans 
2004 80 0.242 0.093 0.018 0.122 0.075 
2005 337 0.253 0.169 0.028 0.125 0.138 
2006 476 0.236 0.154 0.031 0.126 0.123 
2007 495 0.245 0.165 0.035 0.140 0.130 
2008 507 0.254 0.181 0.042 0.130 0.139 
2009 527 0.216 0.147 0.038 0.150 0.109 
2010 504 0.234 0.151 0.038 0.144 0.111 
2011 483 0.236 0.150 0.037 0.135 0.112 
2012 455 0.229 0.142 0.039 0.139 0.103 
2013 377 0.211 0.132 0.036 0.148 0.090 
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Table 1b 
Descriptive statistics for firm characteristics. 
This table reports descriptive statistics for firm characteristics over the period 2004-2013. All variables are scaled by the beginning 
of the year total assets except Tobin’s Q, Sales growth and Employee. The sample includes firms from 17 European countries 
covered by Worldscope and Capital IQ over the period 2004-2013. Panel A reports average values of the firm characteristics for 
the whole period, while Panel B reports their average values for each year. 
Panel A: Full sample 
 R&D 
Cash 
flow 
Stock 
issues 
Tobin’s  
Q 
Sales 
growth 
Cash  ∆Cash  Employee 
Mean 0.040 0.113 0.014 1.574 0.053 0.126 -0.002 15,860 
Median 0.021 0.110 0.000 1.357 0.052 0.091 0.00 2,841 
Standard deviation 0.054 0.106 0.084 0.837 0.190 0.117 0.095 40,902 
No. of observations 4,246 4,246 4,246 4,246 4,246 4,246 4,246 4,246 
No. of firms 939 939 939 939 939 939 939 939 
Panel B: Descriptive statistics by year 
Year N R&D 
Cash 
flow 
Stock 
issues 
Tobin’s  
Q 
Sales 
growth 
Cash  ∆Cash  Employee 
2004 80 0.045 0.132 0.006 1.688 0.053 0.132 0.008 47,249 
2005 336 0.049 0.142 0.020 1.719 0.072 0.137 0.009 20,574 
2006 478 0.046 0.131 0.021 1.877 0.099 0.140 -0.001 15,255 
2007 497 0.041 0.132 0.013 1.751 0.089 0.128 -0.011 13,690 
2008 508 0.037 0.100 0.010 1.263 0.034 0.112 -0.019 14,021 
2009 528 0.036 0.077 0.015 1.403 -0.103 0.119 0.003 13,993 
2010 504 0.036 0.115 0.011 1.512 0.135 0.130 0.017 14,586 
2011 483 0.037 0.109 0.014 1.417 0.082 0.119 -0.017 15,759 
2012 455 0.041 0.117 0.011 1.564 0.091 0.129 0.002 15,411 
2013 377 0.038 0.106 0.011 1.761 -0.016 0.127 -0.001 16,080 
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Table 1c 
Descriptive statistics for firm characteristics for subsamples. 
This table reports descriptive statistics for firm-specific characteristics and debt-related variables for our subsample of firms, which 
are classified as young (small) and mature (large). It also shows t-test (Wilcoxon) for the differences in means (medians) of the 
variables. All variables are scaled by the beginning of year total assets except Tobin’s Q, Sales growth and Employee. The sample 
consists of non-utilities (excluding SIC codes 4900-4949) and non-financial (excluding SIC codes 6000-6999) firms from 17 major 
European countries covered by Worldscope and Capital IQ over the period 2004-2013. ***, **, and * indicate statistical significance 
at the 1%, 5%, and 10% levels, respectively. 
 (1) (2) (3) (4) (5) (6) (7) 
 Full 
Sample 
Young Mature  Small Large  
Variables Mean 
[Median] 
Mean 
[Median] 
Mean 
[Median] 
(t-test) 
[Wilcoxon] 
Mean 
[Median] 
Mean 
[Median] 
(t-test) 
[Wilcoxon] 
R&D 0.040 0.050 0.029 (12.20)*** 0.045 0.027 (9.70)*** 
[0.021] [0.024] [0.019] [9.40]*** [0.023] [0.018] [9.30]*** 
Cash flow 0.113 0.110 0.120 (-1.60) 0.111 0.120 (-1.43) 
[0.110] [0.11] [0.11] [-0.12] [0.11] [0.11] [0.29] 
Stock issues 0.014 0.023 0.003 (7.80)*** 0.020 -0.001 (7.65)*** 
[0.000] [0.000] [0.000] [5.76]*** [0.000] [0.000] [9.63]*** 
Tobin’s Q 1.574 1.639 1.508 (4.80)*** 1.590 1.540 (1.58) 
[1.357] [1.390] [1.324] [3.30]*** [1.33] [1.39] [-3.00]*** 
Sales growth 0.053 0.060 0.045 (2.69)*** 0.054 0.050 (0.46) 
[0.052] [0.056] [0.047] [2.67]*** [0.053] [0.051] [0.47] 
Cash 0.126 0.142 0.110 (8.90)*** 0.131 0.116 (3.86)*** 
[0.091] [0.099] [0.085] [6.50]*** [0.091] [0.09] [0.24] 
Employee 15,860 7,696 24,569 (-13.68)*** 2,150 47,878 (-38.72)*** 
[2,841] [1,616] [5,712] [-20.20]*** [1317] [23,819] [-51.50]*** 
Leverage 0.235 0.235 0.234 (0.45) 0.230 0.250 (-4.10)*** 
[0.21] [0.20] [0.214] [-1.58] [0.20] [0.23] [-6.20]*** 
Bank debt 0.154 0.169 0.141 (5.64)*** 0.176 0.104 (14.78)*** 
 [0.115] [0.125] [0.107] [3.9]*** [0.143] [0.067] [15.94]*** 
Used credit lines  
  
0.036 0.035 0.037 (-0.87) 0.042 0.023 (8.10)*** 
[0.00] [0.00] [0.00] [-2.91]*** [0.00] [0.00] [3.20]*** 
Term loans 0.117 0.129 0.103 [6.05]*** 0.133 0.081 (11.06)*** 
 [0.065] 0.072 0.056 [4.2]*** [0.082] [0.038] [9.65]*** 
No. of observations 4,246 2,188 2,058  2,952 1,294  
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Table 2   
R&D investment regressions. 
This table reports coefficient estimates using the system-GMM estimation method with lagged levels dated t-3 and t-4 used as 
instruments for the equations in differences and lagged differences dated t-2 employed as instruments for the equations in levels. 
We control for year and firm fixed effects in all regressions. Robust standard errors are in parentheses and clustered at the firm 
level. ***, **, and * indicate statistical significance at the 1%, 5%, and 10% levels, respectively. 
 (1) (2) (3) (4) (5) (6) 
R&D i, t-1 
 
1.140*** 1.129*** 1.105*** 1.111*** 1.092*** 1.086*** 
(0.099) (0.099) (0.093) (0.096) (0.091)    (0.090)    
𝑅&𝐷𝑖,𝑡−1
2  
 
-0.613** -0.602** -0.570** -0.527** -0.561**  -0.557**  
(0.278) (0.287) (0.262) (0.258) (0.253)    (0.248)    
Cash flowi,t 
 
0.100*** 0.107*** 0.092*** 0.093*** 0.096*** 0.098*** 
(0.036) (0.034) (0.033) (0.031) (0.033)    (0.030)    
Cash flowi,t-1 
 
-0.082** -0.089*** -0.074** -0.073** -0.072**  -0.073**  
(0.034) (0.032) (0.032) (0.031) (0.033)    (0.030)    
Stock issuesi,t 
 
0.077*** 0.094*** 0.078*** 0.065*** 0.079*** 0.080*** 
(0.029) (0.029) (0.024) (0.022) (0.025)    (0.024)    
Stock issuesi,t-1 
 
-0.027 -0.025 -0.023 -0.036 -0.020 -0.019 
(0.031) (0.028) (0.030) (0.032) (0.029)    (0.028)    
Tobin’s Qi,t 
 
0.005 0.002 0.002 0.004 0.002 0.001 
(0.003) (0.003) (0.003) (0.003) (0.003)    (0.003)    
Tobin’s Qi,t-1 
 
-0.005* -0.003 -0.003 -0.004* -0.003 -0.003 
(0.003) (0.002) (0.002) (0.003) (0.002)    (0.002)    
Sales growthi,t 
 
0.000 0.001 -0.004 -0.002 -0.004 -0.006 
(0.018) (0.016) (0.016) (0.015) (0.015)    (0.014)    
Sales growthi,t-1 
 
-0.005 -0.005 -0.010 -0.006 -0.011 -0.011 
(0.012) (0.011) (0.011) (0.011) (0.011)    (0.010)    
∆Cashi,t 
 
-0.030 -0.039 -0.017 -0.013 -0.014 -0.018 
(0.028) (0.025) (0.024) (0.026) (0.025)    (0.024)    
∆Cashi,t-1 -0.040*** -0.038*** -0.038*** -0.039*** -0.037*** -0.036*** 
(0.014) (0.013) (0.013) (0.013) (0.013)    (0.013)    
Leveragei,t 
 
 -0.016     
 (0.021)     
Leveragei,t-1 
 
 0.020     
 (0.020)     
Bank debti,t 
 
  0.011    
  (0.019)    
Bank debti t-1 
 
  0.000    
  (0.017)    
Used credit linesi,t 
 
   0.096**  0.067*   
   (0.046)  (0.040)    
Used credit linesi,t-1 
 
   -0.047  -0.014 
   (0.036)  (0.031)    
Term loansi,t 
 
    -0.017 -0.010 
    (0.017) (0.017)    
Term loansi,t-1 
 
    0.011 0.010 
    (0.018) (0.017)    
       Sum Debt type (p-value) - 0.75 0.41 0.04 0.64 0.02 
Sum term loans (p-value) - - - - - 0.96 
Sum ∆Cash (p-value) 0.02 0.004 0.04 0.05 0.06 0.04 
Sum Cash flow (p-value) 0.59 0.55 0.56 0.51 0.44 0.04 
Sum Stock issues (p-value) 0.20 0.08 0.11 0.36 0.08 0.38 
m1 0.000 0.000 0.000 0.000 0.000 0.000 
m2 0.536 0.376 0.84 0.735 0.689 0.886 
Hansen-J 0.358 0.76 0.408 0.413 0.161 0.597 
Difference-in-Hansen 0.659 0.878 0.623 0.766 0.645 0.8 
No. of observations 4,246 4,246 4,246 4,246 4,246 4,246 
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Table 3 
R&D investment regressions for young (small) and mature (large) firms. 
This table reports coefficient estimates for young (small) and mature (large) firms using the system-GMM estimation method.  In 
all columns, except in column (2), we use lagged levels dated t-3 and t-4 used as instruments for the equations in differences and 
lagged differences dated t-2 used as instruments for the equations in levels. In column (2) we use lagged levels dated t-4 and 
lagged differences dated t-3 for this group. We control for year and firm fixed effects in all regressions. Robust standard errors 
are in parentheses and clustered at the firm level. ***, **, and indicate statistical significance at the 1%, 5%, and 10% levels, 
respectively.  
Young Mature Small    Large 
   (1)   (2)   (3)      (4) 
R&D i, t-1 
 
1.112*** 1.143*** 1.130*** 1.021*** 
(0.109) (0.077)    (0.099) (0.067)    
𝑅&𝐷𝑖,𝑡−1
2  
 
-0.488* -0.917*** -0.509** -0.778**  
(0.256) (0.282)    (0.251) (0.348)    
Cash flowi,t 
 
0.078*** 0.113*** 0.069** 0.152*** 
(0.028) (0.034)    (0.028) (0.038)    
Cash flowi,t-1 
 
-0.058** -0.129*** -0.054* -0.039**  
(0.029) (0.044)    (0.030) (0.018)    
Stock issues i,t 
 
0.052** 0.024 0.055** 0.050*   
(0.020) (0.050)    (0.022) (0.028)    
Stock issues i,t-1 
 
-0.038 0.059*   -0.045 0.002 
(0.030) (0.031)    (0.030) (0.024)    
Tobin’s Qi,t 
 
0.006* -0.002 0.004 -0.004 
(0.003) (0.002)    (0.003) (0.004)    
Tobin’s Qi,t-1 
 
-0.004 0.003 -0.003 -0.003 
(0.003) (0.003)    (0.003) (0.004)    
Sales growthi,t 
 
-0.002 0.001 -0.005 0.004 
(0.016) (0.009)    (0.015) (0.006)    
Sales growthi,t-1 
 
-0.011 0.003 -0.009 -0.019*** 
(0.011) (0.008)    (0.011) (0.005)    
∆Cashi,t 
 
0.014 -0.065*** 0.011 -0.037 
(0.023) (0.009)    (0.025) (0.024)    
∆Cashi,t-1 -0.042*** -0.043*** -0.037*** -0.044*** 
(0.016) (0.014)    (0.013) (0.015)    
Used credit linesi,t 
 
0.110** 0.070 0.106** 0.038*   
(0.048) (0.057)    (0.053) (0.022)    
Used credit linesi,t-1 
 
-0.029 -0.038 -0.045 -0.028*   
(0.039) (0.047)    (0.038) (0.017)    
          Sum Used credit lines (p-value) 0.02 0.15 0.05 0.63 
Sum ∆Cash (p-value) 0.32 0.00 0.36 0.01 
Sum Cash flow (p-value) 0.51 0.6 0.59 0.01 
Sum Stock issues (p-value) 0.61 0.12 0.74 0.16 
m1 0.000 0.000 0.000 0.000 
m2 0.654 0.459 0.950 0.780 
Hansen-J 0.204 0.885 0.240 0.500 
Difference-in-Hansen 0.300 0.420 0.650 0.810 
No. of observations  2,188 2,058 2,952 1,294 
 
 
 
 
Table 4 
R&D investment regressions for firms with low and high R&D. 
This table reports coefficient estimates for low and high R&D firms, and high R&D firms with low and high cash holdings, low and high stock issues, and low and high cash flows. We use the system-
GMM estimation method. In all columns, except in columns (5) and (6), we use lagged levels dated t-3 and t-4 used as instruments for the equations in differences and lagged differences dated t-2 used as 
instruments for the equations in levels.  In column (5), we use lagged levels dated t-4 and lagged differences dated t-3, while in column (6), we use lagged levels dated t-2 and lagged differences dated t-1. 
We control for year and firm fixed effects in all regressions. Robust standard errors are in parentheses and clustered at the firm level. ***, **, and indicate statistical significance at the 1%, 5%, and 10% 
levels, respectively. 
 
 
 
 
 
Low R&D 
 
 
High R&D 
 
 
High R&D,  
low cash  
   
High R&D, 
 high cash  
High R&D,  
low stock  
High R&D,  
high stock  
High R&D,  
low CF  
High R&D,  
high CF  
 (1) (2) (3) (4) (5) (6) (7) (8) 
R&D i, t-1 
 
0.565*** 1.109*** 1.046*** 1.043*** 1.297*** 1.165*** 1.092*** 1.126*** 
 (0.158) (0.105)    (0.153) (0.109)    (0.114) (0.109)    (0.117) (0.104)    
𝑅&𝐷𝑖,𝑡−1
2  
 
0.139 -0.596**  -0.949* -0.475**  -1.602*** -0.637*** -0.830*** -0.657*** 
 (1.329) (0.251)    (0.561) (0.222)    (0.383) (0.205)    (0.272) (0.243)    
Cash flowi,t 
 
0.018 0.095*** 0.050* 0.115*** 0.080*** 0.147*** 0.086*** 0.087*** 
(0.014) (0.031)    (0.026) (0.037)    (0.030) (0.036)    (0.027) (0.028)    
Cash flowi,t-1 
 
-0.021* -0.090*** -0.070*** -0.096*** -0.078** -0.105*** -0.064** -0.080*** 
(0.011) (0.032)    (0.025) (0.033)    (0.031) (0.029)    (0.032) (0.026)    
Stock issues i,,t 
 
0.003 0.057**  0.089 0.048**  -0.031 0.054**  0.074*** -0.006 
(0.012) (0.023)    (0.055) (0.021)    (0.036) (0.026)    (0.026) (0.022)    
Stock issues i,,t-1 
 
-0.012* -0.031 -0.002 -0.043 -0.018 -0.054**  -0.060** -0.071*   
(0.007) (0.031)    (0.023) (0.028)    (0.035) (0.022)    (0.025) (0.039)    
Tobin’s Qi,t 
 
0.001 0.005 0.008** 0.002 0.005 0.004 0.001 0.001 
(0.002) (0.003)    (0.004) (0.003)    (0.004) (0.004)    (0.004) (0.003)    
Tobin’s Qi,t-1 
 
0.000 -0.004 -0.004 0.000 0.003 0.003 0.001 -0.001 
(0.001) (0.003)    (0.004) (0.003)    (0.003) (0.004)    (0.004) (0.003)    
Sales growthi,t 
 
0.010* -0.011 -0.006 -0.016 -0.029 -0.018 -0.003 0.009 
(0.006) (0.020)    (0.016) (0.019)    (0.022) (0.023)    (0.019) (0.018)    
Sales growthi,t-1 
 
0.002 -0.013 -0.008 -0.003 -0.020 -0.021*   -0.027** -0.005 
(0.003) (0.013)    (0.010) (0.014)    (0.017) (0.011)    (0.011) (0.016)    
∆Cashi,t 
 
-0.028* -0.022 0.022 -0.018 0.016 -0.036 -0.040 -0.007 
(0.015) (0.027)    (0.037) (0.022)    (0.037) (0.022)    (0.034) (0.019)    
∆Cashi,t-1 -0.005 -0.051
*** 0.036 -0.065*** -0.038 -0.043*** -0.054** -0.043*** 
(0.005) (0.019)    (0.025) (0.017)    (0.028) (0.014)    (0.025) (0.014)    
Used credit linesi,t 
 
0.014 0.150*** 0.075** 0.085 0.125* 0.172**  0.094* 0.121**  
(0.023) (0.048)    (0.031) (0.066)    (0.066) (0.079)    (0.053) (0.049)    
Used credit linesi,t-1 
 
-0.009 -0.054 0.006 -0.076 -0.012 -0.103 -0.040 -0.041 
(0.022) (0.040)    (0.027) (0.050)    (0.055) (0.067)    (0.046) (0.040)    
         
Sum Used credit lines (p-value) 0.48 0.02 0.023 0.87 0.04 0.31 0.24 0.03 
Sum ∆Cash (p-value) 0.07 0.03 0.25 0.01 0.701 0.01 0.07 0.03 
Sum Cash flow (p-value) 0.83 0.87 0.44 0.54 0.94 0.26 0.42 0.81 
Sum Stock issues (p-value) 0.61 0.45 0.21 0.87 0.42 0.99 0.67 0.07 
m1 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
m2 0.632 0.189 0.945 0.489 0.705 0.100 0.459 0.387 
Hansen-J  0.567 0.398 0.397 0.232 0.483 0.237 0.204 0.430 
Difference-in-Hansen 0.639 0.646 0.672 0.174 0.668 0.806 0.772 0.688 
No. of observations  2,125 2,121 877 1,244 1,254 867 738 1,383 
 
 
 
  Table 5 
  Difference-in-differences estimations for the effect of crises on R&D investment. 
This table reports coefficient estimates for the impact of the 2007-2009 financial crisis and the European sovereign debt crisis 
on financing of R&D investments. Crisis is a dummy variable that is 1 for the period 2007-2009, and 0 otherwise in columns 
(1) and (2); it is equal to 1 for the period 2010-2013, and 0 otherwise in columns (3) and (4). We use the system-GMM estimation 
method with lagged levels dated t-3 and t-4 used as instruments for the equations in differences and lagged differences dated t-
2 used as instruments for the equations in levels. We control for year and firm fixed effects in all regressions. Robust standard 
errors are in parentheses and clustered at the firm level. ***, **, and * indicate statistical significance at the 1%, 5%, and 10% 
levels, respectively. 
 2007-2009 Financial Crisis  European Sovereign Debt Crisis  
   (1)      (2)          (3)         (4) 
∆Cashi,t 
 
-0.013 -0.036 -0.013 -0.026  
(0.026) (0.036)    (0.026) (0.028)  
∆Cashi,t-1 -0.039*** -0.056*   -0.039*** -0.026**  
(0.013) (0.033)    (0.013) (0.012)  
∆Cashi,t * Crisis 
 
 0.043  0.009  
 (0.056)     (0.059)  
∆Cashi,t-1* Crisis 
 
 0.025  -0.091***  
 (0.036)     (0.034)  
Used credit linesi,t 
 
0.100** 0.096**  0.095** 0.114**  
(0.047) (0.047)    (0.049) (0.047)  
Used credit linesi,t-1 
 
-0.044 -0.039 -0.040 -0.049  
(0.036) (0.036)    (0.040) (0.039)  
Used credit linesi,t* Crisis 
 
0.001 0.000 -0.006 -0.005  
(0.021) (0.021)    (0.027) (0.027)  
Used credit linesi,t-1* Crisis 
 
-0.011 -0.014 -0.009 -0.005  
(0.014) (0.015)    (0.020) (0.022)  
      
Other firm-level controls used Yes Yes Yes Yes  
Sum Used credit lines (p-value) 0.03 0.029 0.05 0.02  
Sum Used credit lines* Crisis (p-value) 0.61 0.51 0.56 0.69  
Sum ∆Cash (p-value) 0.05 0.08 0.06 0.05  
Sum ∆Cash *Crisis (p-value) - 0.34 - 0.29  
m1 0.000 0.000 0.000 0.000  
m2 0.727 0.737 0.739 0.942  
Hansen-J 0.395 0.4 0.348 0.35  
Difference-in-Hansen 0.74 0.74 0.72 0.81  
No. of observations 4,246 4,246 4,246 4,246  
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Table 6 
Difference-in-differences estimations for the effect of crises on R&D investment for young (small) and mature (large) firms.   
This table reports coefficient estimates for the impact of the 2007-2009 financial crisis and the European sovereign debt crisis on financing 
of R&D investments for young (small) and mature (large) firms. Crisis is a dummy variable that is 1 for the period 2007-2009, and 0 
otherwise in columns (1) to (4); it is equal to 1 for the period 2010-2013, and 0 otherwise in columns (5) to (8). We use the system-GMM 
estimation method with lagged levels dated t-3 and t-4 used as instruments for the equations in differences and lagged differences dated t-
2 used as instruments for the equations in levels. We control for year and firm fixed effects in all regressions. Robust standard errors are 
in parentheses and clustered at the firm level. For brevity, we do not report the coefficient estimates of the firm-level control variables, as 
shown in Equation (1). ***, **, and * indicate statistical significance at the 1%, 5%, and 10% levels, respectively.  
   2007-2009 Financial Crisis                          .    European Sovereign Debt Crisis                         .  
 Young 
  (1) 
Mature 
   (2) 
Small 
   (3) 
Large 
(4) 
  Young 
(5) 
Mature 
    (6) 
Small 
     (7) 
Large 
    (8) 
∆Cashi,t 0.003 -0.065*** 0.000 -0.036 0.008 -0.074*** -0.004 -0.049**  
 (0.036) (0.023) (0.037) (0.030)    (0.025) (0.013)    (0.027) (0.025)    
∆Cashi,t-1 -0.042 -0.038 -0.052 -0.032*   -0.027* -0.034**  -0.024** -0.047*** 
 (0.034) (0.028) (0.033) (0.017)    (0.015) (0.016)    (0.011) (0.015)    
∆Cashi,t*Crisis 0.025 -0.018 0.015 0.003 -0.011 0.092*** 0.018 0.06 
 (0.051) (0.057) (0.054) (0.044)    (0.052) (0.035)    (0.059) (0.039)    
∆Cashi,t-1*Crisis 0.003 0.023 0.022 -0.022 -0.083** -0.048 -0.084** 0.018 
 (0.038) (0.042) (0.036) (0.022)    (0.035) (0.059)    (0.034) (0.036)    
Used credit linesi,t 
 
0.116** 0.128* 0.097* 0.04 0.145*** 0.028 0.127** 0.040*   
(0.048) (0.069) (0.053) (0.025)    (0.055) (0.033) (0.055) (0.022)    
Used credit linesi,t-1 
 
-0.021 -0.085* -0.039 -0.020 -0.029 -0.030 -0.037 -0.029*   
(0.038) (0.050) (0.039) (0.019)    (0.046) (0.021) (0.042) (0.016)    
Used credit linesi,t* Crisis 
 
0.014 -0.038 0.029 0.001 -0.038 0.085** -0.031 0.003 
(0.036) (0.030) (0.028) (0.015)    (0.039) (0.037) (0.032) (0.026)    
Used credit linesi,t-1* Crisis 
 
-0.045* 0.018 -0.014 -0.016 0.013 -0.033 -0.023 0.031 
(0.025) (0.019) (0.019) (0.017)    (0.030) (0.026) (0.027) (0.026)    
         
Other firm-level controls used Yes Yes Yes Yes Yes Yes Yes Yes 
Sum Used credit lines (p-value) 0.008 0.16 0.07 0.50 0.01 0.92 0.013 0.52 
Sum Used credit line*Crisis  
(p-value) 
0.43 0.43 0.61 0.45 0.54 0.81 0.41 0.12 
Sum ∆Cash (p-value) 0.52 0.02 0.36 0.05 0.49 0.00 0.30 0.003 
Sum ∆Cash *Crisis (p-value) 0.73 0.95 0.61 0.72 0.18 0.59 0.41 0.12 
m1 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
m2 0.732 0.358 0.935 0.672 0.748 0.556 0.898 0.771 
Hansen-J 0.321 0.466 0.23 0.515 0.174 0.12 0.35 0.478 
Difference-in-Hansen 0.385 0.525 0.633 0.658 0.431 0.43 0.65 0.82 
No. of observations  2,188 2,058 2,952 1,294 2,188 2,058 2,952 1,294 
 
 
 
Table 7a 
Difference-in-differences estimations for the effect of crises on R&D investments in bank-based countries.  
This table reports coefficient estimates for the impact of the 2007-2009 and the European sovereign debt crisis on financing of R&D 
investments in bank-based countries. Bank-based is a dummy variable that is 1 if a country has a bank-based economy, and 0 for a 
market-based economy. Crisis is a dummy variable that is 1 for the period 2007-2009, and 0 otherwise in column (2), while it is 
equal to 1 for the period 2010-2013, and 0 otherwise in column (3). We use the system-GMM estimation method with lagged levels 
dated t-3 and t-4 used as instruments for the equations in differences and lagged differences dated t-2 used as instruments for the 
equations in levels. We control for year and firm fixed effects. Robust standard errors are in parentheses and clustered at the firm 
level. For brevity, we do not report the coefficient estimates of firm-level control variables, as shown in Equation (1). ***, **, and * 
indicate statistical significance at the 1%, 5%, and 10% levels, respectively.  
 
                                                                                          
 
2007-2009 Crisis                       
. 
 
Sovereign Debt Crisis                 
.  (1) (2) (3) 
∆Cashi,t -0.033 -0.057 -0.015 
 (0.032)    (0.035)    (0.029)    
∆Cashi,t-1 -0.062**  -0.077*** -0.036*** 
 (0.024)    (0.029)    (0.012)    
∆Cashi,t*Crisis  0.113*   0.062 
  (0.063)    (0.051)    
∆Cashi,t-1*Crisis  0.038 -0.039 
  (0.041)    (0.028)    
∆Cashi,t* Bank-based -0.02   
 (0.039)      
∆Cashi,t-1* Bank-based 0.080*     
 (0.044)      
∆Cashi,t*Crisis* Bank-based  -0.115*   -0.165**  
  (0.068)    (0.075)    
∆Cashi,t-1*Crisis* Bank-based  0.018 0.104*   
  (0.040)    (0.059)    
Used credit linesi,t -0.007 0.078 0.119**  
  (0.055)    (0.048)    (0.050)    
Used credit linesi,t-1 -0.011 -0.024 -0.044 
  (0.055)    (0.044)    (0.040)    
Used credit linesi,t*Crisis  -0.022 0.042 
   (0.042)    (0.031)    
Used credit linesi,t-1*Crisis  -0.032 -0.015 
   (0.026)    (0.025)    
Bank-based -0.013**  -0.008** 0.001 
 (0.006)    (0.003) (0.004) 
Used credit linesi,t * Bank-based  0.127   
 (0.084)      
Used credit linesi,t-1* Bank-based  -0.012   
 (0.078)      
Used credit linesi,t*Crisis*Bank-based  0.176 -0.156 
   (0.122)    (0.111)    
Used credit linesi,t-1*Crisis*Bank-based  0.04 0.068 
   (0.042)    (0.100)    
    
Other firm-level controls used Yes Yes Yes 
Sum Used credit lines (p-value) 0.48 0.06 0.01 
Sum Used credit lines*Crisis(p-value) - 0.25 0.41 
Sum Used credit lines*Crisis*Bank-based (p-value) - 0.09 0.05 
Sum Used credit lines* Bank-based (p-value) 0.06 - - 
Sum ∆Cash (p-value) 0.04 0.00 0.12 
Sum ∆Cash *Crisis (p-value) - 0.08 0.70 
Sum ∆Cash *Crisis*Bank-based  (p-value) - 0.32 0.60 
Sum ∆Cash *Bank-based  (p-value) 0.41 - - 
m1 0.000 0.000 0.000 
m2 0.485 0.92 0.944 
Hansen-J 0.704 0.473 0.317 
Difference-in-Hansen 0.962 0.853 0.669 
No. of observations 4,246 4,246 4,246 
 
 
Table 7b  
Difference-in-differences estimations for the effect of crises on R&D investment for young (small) and mature (large) firms in bank-based countries.  
This table reports coefficient estimates for the impact of the 2007-2009 financial crisis and the European sovereign debt crisis on financing of R&D investments for young 
(small) and mature (large) firms in bank-based countries. Bank-based is a dummy variable that is 1 if a country has a bank-based economy, and 0 for a market-based economy. 
Crisis is a dummy variable that is 1 for the period 2007-2009, and 0 otherwise in columns (1) to (4), while it is equal to 1 for the period 2010-2013, and 0 otherwise in columns 
(5) to (8). We use the system-GMM estimation method. In all columns, except in column (2), lagged levels dated t-3 and t-4 are used as instruments for the equations in 
differences, and lagged differences dated t-2 are used as instruments for the equations in levels. In column (2), we use lagged levels dated t-4 and lagged differences dated t-3 
for the mature firms. We control for year and firm fixed effects. Robust standard errors are in parentheses and clustered at the firm level. For brevity, we do not report the 
coefficient estimates of firm-level control variables, as shown in Equation (1).  ***, **, and * indicate statistical significance at the 1%, 5%, and 10% levels, respectively. 
 
 
 Panel A: 2007-2009 Financial Crisis                                  . Panel B: European Sovereign Debt Crisis                    . 
 Young  Mature  Small  Large  Young  Mature  Small  Large  
 (1) (2) (3) (4) (5) (6) (7) (8) 
∆Cashi,t 0.014 -0.055** 0.014 -0.041 0.020 -0.055*** -0.038 -0.051**  
 (0.032) (0.026) (0.043) (0.028)    (0.030) (0.007) (0.025) (0.025)    
∆Cashi,t-1 -0.041 -0.046 -0.047 -0.042**  -0.041*** -0.028*** -0.044*** -0.046**  
 (0.025) (0.028) (0.030) (0.020)    (0.016) (0.008) (0.013) (0.021)    
∆Cashi,t*Crisis 0.048 0.005 0.065 -0.002 0.036 0.126*** 0.099** 0.034 
 (0.050) (0.050) (0.067) (0.065)    (0.046) (0.031) (0.046) (0.032)    
∆Cashi,t-1*Crisis 0.004 0.027 0.027 0.018 -0.039 -0.002 -0.039 0.047**  
 (0.036) (0.038) (0.039) (0.035)    (0.027) (0.039) (0.039) (0.022)    
∆Cashi,t*Crisis* Bank-based -0.087 -0.008 -0.160** 0.012 -0.196*** -0.092* -0.181** 0.052*   
 (0.072) (0.057) (0.073) (0.059)    (0.071) (0.050) (0.081) (0.030)    
∆Cashi,t-1*Crisis* Bank-based 0.026 -0.015 0.017 -0.073 0.08 -0.078 0.054 -0.025 
 (0.039) (0.037) (0.055) (0.061)    (0.052) (0.057) (0.050) (0.028)    
Used credit linesi,t 0.090** 0.061 0.158** 0.035*   0.158*** 0.039 0.107** 0.032 
  (0.043) (0.039) (0.062) (0.021)    (0.054) (0.029) (0.047) (0.024)    
Used credit linesi,t-1 -0.018 -0.029 -0.073 -0.024 -0.033 -0.030 -0.01 -0.034 
  (0.036) (0.031) (0.062) (0.017)    (0.042) (0.020) (0.040) (0.023)    
Used credit linesi,t*Crisis -0.013 -0.060 -0.012 0.009 0.010 0.040 0.019 -0.002 
  (0.034) (0.039) (0.072) (0.032)    (0.043) (0.042) (0.035) (0.027)    
Used credit linesi,t-1*Crisis -0.048* 0.010 -0.066 0.013 0.016 -0.001 -0.031 0.012 
  (0.025) (0.022) (0.060) (0.021)    (0.031) (0.023) (0.026) (0.023)    
Bank-based -0.008** -0.001 -0.006 0.000 0.001 0.001 0.002 0.000 
 (0.003) (0.003) (0.004) (0.002)    (0.005) (0.002) (0.005) (0.002)    
Used credit linesi,t*Crisis*Bank-based 0.133 0.067 0.174 -0.009 -0.079 -0.116 -0.059 -0.027 
  (0.104) (0.063) (0.192) (0.044) (0.117) (0.080) (0.129) (0.063)    
Used credit linesi,t-1*Crisis*Bank-based 0.032 -0.006 0.133 -0.050 -0.053 0.088 -0.018 0.034 
  (0.054) (0.028) (0.137) (0.048)    (0.102) (0.055) (0.117) (0.052)    
Other firm-level controls used Yes Yes Yes Yes Yes Yes Yes Yes 
Sum Used credit lines (p-value) 0.03 0.17 0.03 0.57 0.01 0.61 0.01 0.94 
Sum Used credit lines*Crisis (p-value) 0.12 0.16 0.21 0.52 0.55 0.24 0.71 0.73 
Sum Used credit lines*Crisis*Bank-based (p-value) 0.08 0.31 0.09 0.35 0.06 0.57 0.09 0.86 
                         (Continued) 
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Table 7b (Continued)         
Sum ∆Cash (p-value) 0.51 0.01 0.57 0.03 0.58 0 0.01 0.009 
Sum ∆Cash*Crisis (p-value) 0.45 0.62 0.30 0.85 0.96 0.004 0.39 0.04 
Sum ∆Cash*Crisis*Bank-based (p-value) 0.52 0.75 0.214 0.55 0.29 0.04 0.27 0.47 
m1  0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
m2 0.775 0.419 0.608 0.782 0.821 0.922 0.752 0.681 
Hansen-J 0.216 0.879 0.566  0.466 0.386 0.360 0.546 0.451 
Difference-in-Hansen  0.630 0.746 0.960 0.906 0.570 0.844 0.830 0.903 
No. of observations 2,188 2,058 2,952 1,294 2,188 2,058  2,952 1,294 
 
 
 
 
 
 
1 
 
Table 8 
R&D investment regressions for non-UK subsample. 
This table reports coefficient estimates for the sample, excluding UK firms.  We use the system-GMM method with lagged levels 
dated t-3 and t-4 used as instruments for the equations in differences and lagged differences dated t-2 used as instruments for the 
equations in levels. We control for year and firm fixed effects.  Robust standard errors are in parentheses and clustered at the firm 
level. ***, **, and * indicate statistical significance at the 1%, 5%, and 10% levels, respectively. 
  Non-UK Sample 
R&D i, t-1  1.010***  
 (0.123) 
𝑅&𝐷𝑖,𝑡−1
2   -0.340  
 (0.557) 
Cash flowi,t  0.096*** 
  (0.028) 
Cash flowi,t-1  -0.081*** 
  (0.031) 
Stock issues i, t  0.033 
  (0.039) 
Stock issues i, t-1  0.011 
  (0.048) 
Tobin’s Qi,t  0.003 
  (0.004) 
Tobin’s Qi,t-1  -0.001 
  (0.003) 
Sales growthi,t  -0.007 
  (0.016) 
Sales growthi,t-1  -0.001 
  (0.009) 
∆Cashi,t  -0.023 
  (0.025) 
∆Cashi,t-1  -0.027** 
  (0.014) 
Used credit linesi,t  0.083** 
  (0.044) 
Used credit linesi,t-1  -0.033 
  (0.031) 
   
Sum Used credit lines (p-value)  0.08 
Sum ∆Cash (p-value)  0.08 
Sum Cash flow (p-value)  0.60 
Sum Stock issues (p-value)  0.44 
m1  0.00 
m2  0.95 
Hansen-J  0.64 
Difference-in-Hansen  0.82 
No. of observations   2,992 
No. of firms  680 
